
<html lang="en"     class="pb-page"  data-request-id="b3b3f795-66c7-4080-a969-c64fc98ccc38"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-3;pageGroup:string:Publication Pages;article:article:10.1021/jm201533b;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists" /></meta><meta name="dc.Creator" content="Mohamed A.  Ibrahim" /></meta><meta name="dc.Creator" content="Henry W. B.  Johnson" /></meta><meta name="dc.Creator" content="Joon Won  Jeong" /></meta><meta name="dc.Creator" content="Gary L.  Lewis" /></meta><meta name="dc.Creator" content="Xian  Shi" /></meta><meta name="dc.Creator" content="Robin T.  Noguchi" /></meta><meta name="dc.Creator" content="Matthew  Williams" /></meta><meta name="dc.Creator" content="James W.  Leahy" /></meta><meta name="dc.Creator" content="John M.  Nuss" /></meta><meta name="dc.Creator" content="John  Woolfrey" /></meta><meta name="dc.Creator" content="Monica  Banica" /></meta><meta name="dc.Creator" content="Frauke  Bentzien" /></meta><meta name="dc.Creator" content="Yu-Chien  Chou" /></meta><meta name="dc.Creator" content="Anna  Gibson" /></meta><meta name="dc.Creator" content="Nathan  Heald" /></meta><meta name="dc.Creator" content="Peter  Lamb" /></meta><meta name="dc.Creator" content="Larry  Mattheakis" /></meta><meta name="dc.Creator" content="David  Matthews" /></meta><meta name="dc.Creator" content="Aaron  Shipway" /></meta><meta name="dc.Creator" content="Xiang  Wu" /></meta><meta name="dc.Creator" content="WenTao  Zhang" /></meta><meta name="dc.Creator" content="Sihong  Zhou" /></meta><meta name="dc.Creator" content="Geetha  Shankar" /></meta><meta name="dc.Description" content="A series of subtype selective sphingosine 1-phosphate receptor 1 (S1P1) antagonists are disclosed. Our high-throughput screening campaign revealed hit 1 for which an increase in potency and mouse o..." /></meta><meta name="Description" content="A series of subtype selective sphingosine 1-phosphate receptor 1 (S1P1) antagonists are disclosed. Our high-throughput screening campaign revealed hit 1 for which an increase in potency and mouse o..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 24, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201533b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201533b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201533b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201533b" /></link>
        
    
    

<title>Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201533b" /></meta><meta property="og:title" content="Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0025.jpeg" /></meta><meta property="og:description" content="A series of subtype selective sphingosine 1-phosphate receptor 1 (S1P1) antagonists are disclosed. Our high-throughput screening campaign revealed hit 1 for which an increase in potency and mouse oral exposure was achieved with minor modifications to the chemical scaffold. In vivo efficacy revealed that at high doses compounds 12 and 15 inhibited tumor growth. Further optimization of our lead series led to the discovery of proline derivatives 37 (XL541) and 38 which had similar efficacy as our first generation analogues at significantly lower doses. Analogue 37 displayed excellent pharmacokinetics and oral exposure in multiple species." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201533b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201533b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201533b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201533b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201533b&amp;href=/doi/10.1021/jm201533b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1368-1381</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201510p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2016073" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed+A.++Ibrahim">Mohamed A. Ibrahim</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+W.+B.++Johnson">Henry W. B. Johnson</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joon+Won++Jeong">Joon Won Jeong</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+L.++Lewis">Gary L. Lewis</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xian++Shi">Xian Shi</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robin+T.++Noguchi">Robin T. Noguchi</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Williams">Matthew Williams</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Leahy">James W. Leahy</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Nuss">John M. Nuss</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Woolfrey">John Woolfrey</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Banica">Monica Banica</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frauke++Bentzien">Frauke Bentzien</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Chien++Chou">Yu-Chien Chou</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Gibson">Anna Gibson</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathan++Heald">Nathan Heald</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Lamb">Peter Lamb</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Larry++Mattheakis">Larry Mattheakis</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Matthews">David Matthews</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Shipway">Aaron Shipway</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiang++Wu">Xiang Wu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=WenTao++Zhang">WenTao Zhang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sihong++Zhou">Sihong Zhou</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Geetha++Shankar">Geetha Shankar</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (650) 837-7006. Fax: (650) 837-8177. E-mail: <a href="/cdn-cgi/l/email-protection#3a52505552544955547a5f425f565342534914595557"><span class="__cf_email__" data-cfemail="0a62606562647965644a6f726f666372637924696567">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201533b&amp;href=/doi/10.1021%2Fjm201533b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1368â1381</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 3, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 November 2011</li><li><span class="item_label"><b>Published</b> online</span>24 January 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201533b" title="DOI URL">https://doi.org/10.1021/jm201533b</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1368%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMohamed%2BA.%2BIbrahim%252C%2BHenry%2BW.%2BB.%2BJohnson%252C%2BJoon%2BWon%2BJeong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D3%26contentID%3Djm201533b%26title%3DDiscovery%2Bof%2Ba%2BNovel%2BClass%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BSphingosine%2B1-Phosphate%2BReceptor%2B1%2BAntagonists%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1381%26publicationDate%3DFebruary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201533b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2405</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201533b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Novel Class of Potent and Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;A. Ibrahim&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;W. B. Johnson&quot;},{&quot;first_name&quot;:&quot;Joon&quot;,&quot;last_name&quot;:&quot;Won Jeong&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;L. Lewis&quot;},{&quot;first_name&quot;:&quot;Xian&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;T. Noguchi&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Williams&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Leahy&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Nuss&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Woolfrey&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Banica&quot;},{&quot;first_name&quot;:&quot;Frauke&quot;,&quot;last_name&quot;:&quot;Bentzien&quot;},{&quot;first_name&quot;:&quot;Yu-Chien&quot;,&quot;last_name&quot;:&quot;Chou&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Gibson&quot;},{&quot;first_name&quot;:&quot;Nathan&quot;,&quot;last_name&quot;:&quot;Heald&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Lamb&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;Mattheakis&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Matthews&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Shipway&quot;},{&quot;first_name&quot;:&quot;Xiang&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;WenTao&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Sihong&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Geetha&quot;,&quot;last_name&quot;:&quot;Shankar&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1368-1381&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201533b&quot;},&quot;abstract&quot;:&quot;A series of subtype selective sphingosine 1-phosphate receptor 1 (S1P1) antagonists are disclosed. Our high-throughput screening campaign revealed hit 1 for which an increase in potency and mouse oral exposure was achieved with minor modifications to the chemical scaffold. In vivo efficacy revealed that at high doses compounds 12 and 15 inhibited tumor growth. Further optimization of our lead series led to the discovery of proline derivatives 37 (XL541) and 38 which had similar efficacy as our first generation analogues at significantly lower doses. Analogue 37 displayed excellent pharmacokinetics and oral exposure in multiple species.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201533b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201533b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201533b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201533b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201533b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201533b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201533b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201533b&amp;href=/doi/10.1021/jm201533b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201533b" /></input><a href="/doi/pdf/10.1021/jm201533b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201533b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201533b%26sid%3Dliteratum%253Aachs%26pmid%3D22214363%26genre%3Darticle%26aulast%3DIbrahim%26date%3D2012%26atitle%3DDiscovery%2Bof%2Ba%2BNovel%2BClass%2Bof%2BPotent%2Band%2BOrally%2BBioavailable%2BSphingosine%2B1-Phosphate%2BReceptor%2B1%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D3%26spage%3D1368%26epage%3D1381%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jmcmar.2012.55.issue-3/production/jmcmar.2012.55.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of subtype selective sphingosine 1-phosphate receptor 1 (S1P<sub>1</sub>) antagonists are disclosed. Our high-throughput screening campaign revealed hit <b>1</b> for which an increase in potency and mouse oral exposure was achieved with minor modifications to the chemical scaffold. In vivo efficacy revealed that at high doses compounds <b>12</b> and <b>15</b> inhibited tumor growth. Further optimization of our lead series led to the discovery of proline derivatives <b>37</b> (XL541) and <b>38</b> which had similar efficacy as our first generation analogues at significantly lower doses. Analogue <b>37</b> displayed excellent pharmacokinetics and oral exposure in multiple species.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine 1-phosphate (S1P) is a bioactive lipid that has demonstrated effects on a variety of different cellular processes including cell growth, apoptosis, cytoskeletal rearrangement, cell motility, angiogenesis, and vascular maturation.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> Of the five known S1P receptors, sphingosine 1-phosphate receptor 1 (S1P<sub>1</sub>) was the first receptor discovered, and 8 years later it was deorphanized when S1P was disclosed as the natural ligand.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">In 2000, a groundbreaking demonstration of the role S1P<sub>1</sub> plays during vascular maturation in developing embryos was disclosed.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Global deletion of S1P<sub>1</sub> causes embryonic death in mice as a result of excessive intraembryonic hemorrhaging. Interestingly, the developing mice exhibit normal vasculogenesis and angiogenesis but suffer severe impairment in vessel maturation. In addition, the role of S1P<sub>1</sub> in immune regulation was serendipitously unmasked by the clinical benefit seen with the agonist 2-amino-2-(4-octylphenethyl)propane-1,3-diol (fingolimod, FTY720) which causes sequestration of lymphocytes into secondary lymphoid organs and blocks the egress of mature thymocytes from the thymus.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In 2010, fingolimod was approved as the first oral medication for the treatment of multiple sclerosis.</div><div class="NLM_p last">Various reports describing the activity and pharmacology of selective small molecule S1P<sub>1</sub> agonists exist.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> However, fewer efforts to target S1P<sub>1</sub> with selective antagonists have been disclosed.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Knowing that S1P<sub>2</sub> has opposing signaling pathways to S1P<sub>1</sub> and that S1P<sub>3</sub> is implicated in causing undesired cardiac side effects,<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> we aimed to develop a selective, orally bioavailable S1P<sub>1</sub> antagonist for use as a tool to explore the impact of S1P<sub>1</sub> antagonism on angiogenesis and tumor growth.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An extensive screening campaign revealed the dipeptide derivative <b>1</b> having potent and, perhaps more important, selective antagonist activity vs S1P<sub>1</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). However, further evaluation of the pharmacokinetic profile of <b>1</b> demonstrated that no material was observed in the plasma above the limit of detection when dosed orally in mice after 1 and 4 h. It was also discovered that the <i>S</i>-enantiomer (<b>3</b>) gave rise to all the activity observed from the racemate, as it was >18-fold more potent than the <i>R</i>-enantiomer (<b>2</b>). At the outset, our goal was to improve the potency in our cAMP and luciferase selectivity assays, increase the oral exposure, and maintain a >10 Î¼M potency threshold vs the S1P<sub>2</sub> and S1P<sub>3</sub> isoforms.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and early data for racemic HTS hit compound <b>1</b> and optically pure analogues <b>2</b> and <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initially, we wished to determine if the potency of <b>1</b> could be improved by changing functional groups on the periphery of the molecule. Data for analogues such as <b>4</b> and <b>5</b>, containing different sized R groups, indicated it was likely that further modification of this region would be tolerated (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Particularly analogue <b>5</b>, containing a cyclopropanecarboxamide linkage, provided evidence that the <i>N</i>-methylbenzamide group of <b>1</b> could be removed, thereby lowering the molecular weight significantly while retaining modest potency. Comparison of analogues with heterocyclic R groups, such as <b>6</b> and <b>7</b>, indicated that inserting a methylene spacer between the carboxyl group and heterocycle improved the potency >30-fold. In addition, <b>7</b> exhibited significantly higher mouse exposure than the HTS hit <b>1</b> when dosed at 100 mpk: 5 Î¼M (1 h) and 3 Î¼M (4 h) dosed as a solution in 10% EtOH/40% PEG400/water + 1:1 HCl, 100 mpk, or 4.4 Î¼M (1 h) and 0.3 Î¼M (4 h) dosed as a suspension in 10% NMP/corn oil. Improved mouse oral exposure was likely due in part to decreased mouse liver microsome (MLM) oxidation of <b>7</b> compared to HTS hit <b>1</b> (28% for <b>7</b> vs 89% conversion for <b>1</b> at 30 min). N-Substitution on the imidazole with a methyl group to afford <b>8</b> led to a loss in potency. In addition, compounds <b>9</b> and <b>10</b> demonstrated that hydrophobic aryl groups were less tolerated. In summary, optimizing the <i>N</i>-methylbenzamide group present in <b>1</b> allowed us to improve the potency approximately 1 log unit and significantly increase the mouse oral exposure.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Right-Hand Amide Analogues of HTS Lead <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0014.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Racemic material.</p></div></div><div></div></div><div class="NLM_p">Analogues were next explored on the left-hand side, utilizing the optimized imidazole heterocycle as a standard (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). As indicated by compounds <b>11</b>â<b>13</b> and <b>15</b>, placing electron withdrawing substituents around both aryl rings revealed that para-substitution of the phenyl ether was well tolerated. However, for reasons that are not entirely clear, inactive analogue <b>14</b> was an exception to this trend. Alkyl and benzyl substitutions generally resulted in a loss of potency (<b>16</b>, <b>17</b>). Also, interestingly, replacement of the phenoxy phenyl ether linkage with carbon or nitrogen and restricting rotation of this moiety significantly lowered activity (<b>18</b>â<b>21</b>) compared to parent <b>7</b>. Although modifications on the left-hand side of <b>1</b> did not result in as dramatic an improvement in potency as modifications on the right, analogue <b>15</b> demonstrated a â¼2-fold improvement in potency. In addition, the MLM oxidation was lower in both the fluoro and chloro analogues <b>12</b> and <b>15</b> vs the parent <b>7</b> (9% conversion for <b>12</b> and <b>15</b> vs 28% conversion for <b>7</b> at 30 min). Lower MLM data not surprisingly translated to slightly improved mouse oral exposure for both <b>12</b> and <b>15</b> over the des-halogenated parent <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The subtype selectivity was consistently monitored throughout the evolution of the program, and we were pleased to find that compounds <b>12</b> and <b>15</b> compared favorably to HTS hit <b>1</b> in that the S1P<sub>1</sub> activity was improved and a >10 Î¼M potency threshold vs S1P<sub>2</sub> and S1P<sub>3</sub> was maintained.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Serine 4-Phenoxyaniline Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0016.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of Data for Compounds <b>12</b> and <b>15</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0017.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center">luciferase selectivity assay IC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" colspan="2" align="center">mouse PO (100 mg/kg)Â  (Î¼M)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">cAMP assay IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">S1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>2</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub></th><th class="colsep0 rowsep0" align="center">1Â h</th><th class="colsep0 rowsep0" align="center">4Â h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">221</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">11<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">11<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">284</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">8<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">10% EtOH/45% PEG400/water + 1:1 HCl.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">10% EtOH/40% PEG400/water + 1:1 HCl.</p></div></div></div><div class="NLM_p">Lastly, a series of amino acid analogues were explored to probe the SAR of the benzyl ether group (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A comparison of <b>7</b> with <b>22</b> indicated that replacing the ether oxygen with carbon maintained activity. In addition, attempts to truncate the alkyl chain revealed a loss in potency as indicated by <b>23</b> and <b>24</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Benzyl Ether Modifications of Lead Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0018.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0019.gif" alt="" id="fx7" /></img><div></div></div><div class="NLM_p">Since analogues <b>12</b> and <b>15</b> demonstrated good potency and moderate oral bioavailability, we decided to probe the anticancer efficacy of these agents. Specifically, compounds <b>12</b> and <b>15</b> were administered orally to animals implanted with MBA-MB-231T (breast adenocarcinoma) xenografts to determine their effect on tumor growth. We decided to additionally compare our compounds to both the VEGFR2/EGFR antagonist <b>25</b> and Merck S1P1 receptor agonist <b>26</b>.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Tumor growth was measured over time starting on day 14 after implantation (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Data were collected five times over 14 days. Dosing compounds <b>12</b> and <b>15</b> at 300 mpk resulted in tumor growth inhibition of 45% and 54%, respectively, data which were comparable to a lower dosage of both <b>25</b> and <b>26</b>. In addition, in all five xenograft studies minimal weight loss was observed (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of treatment with compounds <b>12</b> and <b>15</b> on MDA-MB-231T tumor volume. Tumor weight is an average of 10 animals per group on day of the indicated treatment. Dosing period was days 14â28.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While it was encouraging that the initial proof-of-concept efficacy study was a success in that the compounds were well tolerated and able to modulate tumor growth, further optimization of this series was desired to produce analogues that could have greater effect at lower doses. In efforts to further improve upon compounds <b>12</b> and <b>15</b>, modification of the serine core was next examined.</div><div class="NLM_p">To this end, methylated amides of compound <b>7</b> were evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). While the substituted alkylamide <b>27</b> led to a â¼1 log unit decrease in activity, the aryl substituted amide <b>28</b> resulted in a more dramatic â¼2.5 log unit loss of activity. Knowing that methylation of the arylamide was not tolerated with compound <b>28</b> and that reducing the number of rotatable bonds often correlates inversely with oral bioavailability, a series of constrained analogues that left the donor/acceptor moiety of the arylamide intact were pursued.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> By utilization of this strategy, benzimidazole <b>29</b> and piperidine <b>30</b> were the first analogues synthesized (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). While neither cyclic derivative improved the potency when compared to <b>15</b>, it was encouraging that modifications of this kind were tolerated.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Serine Amide Methyl Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0020.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">cAMP assay IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8281</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Data for Cyclized Analogues <b>29</b> and <b>30</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0022.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">cAMP assay IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">mouse PO (100 mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">239</td><td class="colsep0 rowsep0" align="left">18.7 Î¼M<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a>(1Â h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">2.7 Î¼M<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a>(4Â h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">6.3 Î¼M<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>(4Â h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">9.2 Î¼M<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>(24Â h)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">10% EtOH/40% PEG400/20% Captisol/water + 1:1 HCl.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">10% NMP/corn oil.</p></div></div></div><div class="NLM_p">Considering the pharmacophoric features of earlier analogues and knowing that substitution of the alkylamide was tolerated, cyclization of the serine core to the proline derivative <b>31</b> was pursued. While <b>31</b> was â¼6-fold less potent than <b>15</b>, we were encouraged that the mouse exposure of this analogue was slightly higher than those of earlier analogues at the 1 h time point (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The increase in exposure appeared to be general in that phenyl derivative <b>32</b> demonstrated mouse exposure levels at 4 and 24 h comparable to levels of other analogues at the earlier 1 and 4 h time points.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Data for Proline Series Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0023.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0024.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">10% NMP/corn oil.</p></div></div><div></div></div><div class="NLM_p">In efforts to reduce the CYP 3A4 liability of analogues <b>31</b> and <b>32</b>, triazoles <b>33</b> and <b>34</b> were synthesized. While triazole analogue <b>33</b> was less active than the parent <b>32</b>, we were pleased to find that triazole <b>34</b> simultaneously optimized CYP 3A4 inhibition, improved the potency â¼1 log unit, and incrementally improved the mouse exposure when compared to the parent <b>31</b>. Fluoro-substituted analogue <b>35</b> was synthesized to improve the MLM oxidation of <b>34</b> (13% conversion at 30 min in <b>34</b> vs 8% conversion in <b>35</b>), which in turn provided greater mouse oral exposure as well. To determine if the stereochemistry at C-4 was optimal, we synthesized the cis isomer <b>36</b>, which was â¼1 log unit less active than the parent trans analogue <b>35</b>. After modulation of the potency and mouse oral exposure to acceptable levels, the 2C9 and 2D6 CYP inhibition observed with <b>35</b> was addressed. Replacement of the 1,2,4-triazole <b>35</b> with the 1,2,3-triazole analogue <b>37</b> (XL541)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> resulted in â¼3-fold less 2D6 and â¼8-fold less 2C9 activity. The 1,2,5-triazole <b>38</b> also had an optimized CYP inhibition profile. As we had anticipated based on data from the serine series, the enantiomer of <b>37</b> again provided evidence that the C-2 <i>R</i>-enantiomer was less potent than the <i>S</i>-enantiomer. Analogues <b>34</b>, <b>35</b>, <b>37</b>, and <b>38</b> were potent in the S1P<sub>1</sub> luciferase selectivity assay and demonstrated a >10 Î¼M activity for S1P<sub>2</sub> and S1P<sub>3</sub>.</div><div class="NLM_p">To determine if the optimized proline series would translate to an improved profile in vivo, we again decided to test the efficacy of our compounds in the MDA-MB-231T mouse xenograft model. Compounds <b>37</b> and <b>38</b> were dosed for 14 days at 100 mpk, at which point we observed a statistically significant 43% and 60% tumor growth inhibition for <b>37</b> and <b>38</b>, respectively, data that were similar to those of earlier leads <b>12</b> and <b>15</b>, albeit at <sup>1</sup>/<sub>3</sub> of the dose (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of treatment with compounds <b>37</b> and <b>38</b> on MDA-MB-231T tumor volume. Tumor weight is an average of 10 animals per group on day of the indicated treatment. Dosing was days 14â28.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the excellent pharmacokinetic profile of <b>37</b> in the mouse and rat, it was chosen to be evaluated in higher order species (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The compound exhibits good oral exposure in rat, dog, and monkey when it is administered as a solution. Bioavailabilities of >40% were observed at 3 mpk along with long half-lives of >6 h. The oral exposure (AUC<sub>0ââ</sub>) observed in the rat was 108 Î¼MÂ·h, and it was 108 Î¼MÂ·h in the dog and 16.7 Î¼MÂ·h in the monkey. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows the pharmacokinetic profile of <b>37</b> when dosed as a solution in cynomolgus monkey at 3 mpk.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacokinetic profile of <b>37</b> in monkey. Compound <b>37</b> dosed at 3 mpk in male cynomolgus monkeys. The iv and po formulation was 5% EtOH/45% PEG400/water.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Oral Pharmacokinetic Parameters for <b>37</b> in Rat, Dog, and Monkey (3 mpk, po)<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">monkey</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (Î¼M)</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">22.5</td><td class="colsep0 rowsep0" align="left">34.0</td><td class="colsep0 rowsep0" align="left">6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0ââ)</sub> (Î¼MÂ·h)</td><td class="colsep0 rowsep0" align="left">107.5</td><td class="colsep0 rowsep0" align="left">107.9</td><td class="colsep0 rowsep0" align="left">16.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">76.4</td><td class="colsep0 rowsep0" align="left">99.9</td><td class="colsep0 rowsep0" align="left">45.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Values reported are the mean of three independent determinations. Compound was dosed as a solution in 5% EtOH/45% PEG400/water.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Serine derivatives <b>1</b>â<b>10</b> and <b>27</b> could be synthesized as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The appropriate protected benzylserine <b>39</b> or <b>40</b> was exposed to 4-phenoxyaniline using peptidic coupling conditions with <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium hexafluorophosphate (HATU), followed by Boc deprotection and diversification with a variety of acid coupling partners. The Boc derivatives <b>11</b>â<b>21</b> and <b>28</b> in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> were synthesized using a similar methodology.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, 4-phenoxyaniline; (b) HCl (4 N in dioxane); (c) RCOOH, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, R-NH<sub>2</sub>; (b) HCl (4 N in dioxane); (c), HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF, 2-(1<i>H</i>-imidazol-5-yl)acetic acid.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> depicts the synthesis of different alkyl amino acids. Starting from the appropriate Boc-protected amino acid, the final compounds <b>22</b>â<b>24</b> were synthesized in a similar manner as described for Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, 4-phenoxyaniline or 4-(4-chlorophenoxy)aniline; (b) HCl (4 N in dioxane); (c) HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF, 2-(1<i>H</i>-imidazol-5-yl)acetic acid.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> depicts the synthesis of benzimidazole derivative <b>29</b>. Coupling of <b>39</b> and <b>43</b> was carried out under peptidic coupling conditions followed by an acidic cyclization and coupling to 2-(1<i>H</i>-imidazol-5-yl)acetic acid to provide final compound <b>29</b>.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (b) AcOH, 60 Â°C; (c) HCl (4 N in dioxane); (d) 4-imidazoleacetic acid hydrochloride, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure><div class="NLM_p">The synthesis of derivative <b>30</b> originated from the diprotected commercially available piperazine <b>44</b> which was elaborated to provide <b>45</b> in a manner similar to previous methods in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Removing the benzyl carbamate (CBz) group followed by reductive amination provided <b>30</b>.</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) 4-(4-fluorophenoxy)aniline, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (b) HCl (4 N in dioxane); (c) 2-(1<i>H</i>-imidazol-5-yl)acetic acid hydrochloride, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (d) H<sub>2</sub>, Pd/C, MeOH; (e) benzaldehyde, MeOH, NaBH(OAc)<sub>3</sub>.</p></p></figure><div class="NLM_p">The trans proline derivatives <b>31</b>â<b>35</b>, <b>37</b>, and <b>38</b> were synthesized as described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> in 10 steps starting from <span class="smallcaps smallerCapital">l</span>-pyroglutamic acid <b>46</b>. Diprotection followed by enolate formation and electrophile addition at low temperature provided alkylated derivatives <b>47</b>â<b>49</b>. As expected, stereochemistry at the C-2 stereocenter was conserved during the alkylation step.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Reduction of the lactam in two steps followed by ester hydrolysis, Boc protection, coupling with the appropriate phenoxyaniline, and Boc deprotection provided <b>50</b>â<b>52</b>. Finally, coupling with the appropriate carboxylic acid provided analogues <b>31</b>â<b>35</b>, <b>37</b>, and <b>38</b>. The synthesis outlined in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> was utilized to provide >100 g of <b>37</b> for nonclinical toxicology studies.</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) <i>t</i>-BuOAc, HClO<sub>4</sub>; (b) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>3</sub>CN; (c) LiHMDS, THF, R-Br, â78 Â°C; (d) LiBEt<sub>3</sub>H, THF, â78 Â°C; (e) Et<sub>3</sub>SiH, BF<sub>3</sub>.Et<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C; (g) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-diisopropylethylamine, dioxane, CH<sub>3</sub>CN; (h) 4-(4-fluorophenoxy)aniline or 4-phenoxyaniline, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (j) Râ²CH<sub>2</sub>COOH, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure><div class="NLM_p">Synthesis of the cis proline derivative <b>36</b>, shown in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, started from commercially available (2<i>S</i>,4<i>R</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (<b>54</b>) and in three steps was elaborated to give <b>55</b>. Oxidation of the alcohol followed by a Wittig reaction and reduction provided <b>36</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, 4-(4-fluorophenoxy)aniline; (b) HCl (4 N in dioxane); (c) 2-(1<i>H</i>-1,2,4-triazol-1-yl)acetic acid, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (d) DMSO, (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, DCM, NEt<sub>3</sub>, â78 Â°C; (e) 4-fluorobenzyltriphenylphosphine chloride, DMSO, NaH, 70 Â°C; (f) Pd/C (10%), MeOH, H<sub>2</sub>.</p></p></figure><div class="NLM_p">Starting from <span class="smallcaps smallerCapital">d</span>-pyroglutamic acid (<b>56</b>), ent-<b>37</b> was synthesized as shown in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a> in a manner similar to that for derivatives in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, using the ethyl ester in place of <i>tert</i>-butyl to give <b>57</b> and carrying out the hydrolysis with lithium hydroxide. Orthogonal protection of the ester was advantageous in that it eliminated the requirement to add the Boc protecting group more than once during the synthesis.</div><figure id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) TsOH; (b) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>3</sub>CN; (c) LiHMDS, THF, 1-(bromomethyl)-4-fluorobenzene, â78 Â°C; (d) LiBEt<sub>3</sub>H, THF, â78 Â°C; (e) Et<sub>3</sub>SiH, BF<sub>3</sub>.Et<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C; (f) KOH, MeOH; (g) 4-(4-fluorophenoxy)aniline, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (i) 2-(1<i>H</i>-1,2,3-triazol-1-yl)acetic acid, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of novel and highly potent S1P<sub>1</sub> antagonists based on the serine and proline structural motif were disclosed. The incorporation of different functional groups on the periphery of HTS hit <b>1</b> had a profound impact on the activity. Further optimization of the serine series led us to explore more constrained analogues such as proline <b>34</b> which provided increased potency and greatly improved mouse oral exposure. In efforts to improve the CYP profile of <b>34</b>, analogues such as <b>37</b> and <b>38</b> were synthesized, and further evaluation of these agents demonstrated that similar efficacy could be achieved at lower doses than comparable serine analogues. In addition, oral administration of <b>37</b> shows excellent pharmacokinetics in multiple species. Further studies demonstrating the pharmacological profile of <b>37</b> will be published in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents and solvents employed were purchased commercially and used without further purification unless otherwise indicated. Melting points were determined on a Melt-Temp melting point apparatus model II and are uncorrected. NMR spectra were recorded on a Varian Mercury Plus 400 MHz instrument. <sup>13</sup>C NMR spectra are assigned with peaks âas observedâ with no comment on splitting patterns. Reported spectra may appear to contain superfluous signals due to the existence of rotamers and/or carbonâfluorine coupling. Chemical shifts are reported in parts per million (ppm) relative to an internal standard of tetramethylsilane in deuterated dimethylsulfoxide (DMSO-<i>d</i><sub>6</sub>) or deuterated chloroform (CDCl<sub>3</sub>). Elemental analyses were conducted by Robertson Microlit Laboratories, Madison, NJ. Positive ion FAB high resolution mass spectrometry was conducted by Analytical Instrument Group, Inc., Raleigh, NC. All final compounds were purified to â¥95% purity as assayed by analytical HPLC (YMC-Pack Pro 150 mm Ã 4.6 mm, 5 Î¼m C18 column, Shimadzu LC-10AT VP system equipped with a Shimadzu SPD-M10A VP diode array detector) at a 1.5 mL/min flow rate with a gradient of 5â95% acetonitrile (containing 0.1% TFA) in 0.1% aqueous TFA for 25 min and total run time of 27 min.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>N</i>-(2-(3-(Benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-ylamino)-2-oxoethyl)-<i>N</i>-methylbenzamide (<b>1</b>)</h3><div class="NLM_p">To a flask charged with <b>39</b> (5.00 g, 16.9 mmol) were added HATU (7.00 g, 18.6 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (8.80 mL, 50.7 mmol). After the mixture was stirred for 15 min 4-phenoxyaniline (3.40 g, 18.6 mmol) was added, and the mixture was stirred at room temperature for 18 h. The reaction mixture was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted twice with ethyl acetate. The combined extracts were washed sequentially with 5% lithium chloride (3Ã), 1 N sodium bicarbonate (2Ã), 5% citric acid (2Ã), water (2Ã), brine and then dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude material was recrystallized from methanol to afford a colorless solid. The solid was combined with HCl (25 mL, 4 N in dioxane). The mixture was stirred at room temperature for 18 h. Volatiles then were removed in vacuo, and the resultant oil was partitioned between 1 N sodium bicarbonate and ethyl acetate. The aqueous layer was extracted with ethyl acetate. The combined extracts were washed with brine (2Ã), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude product was recrystallized from methanol to give rac-<b>41</b> (2.00 g, 5.47 mmol, 33% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.55 (s, 1H), 7.60â7.50 (m, 2H), 7.40â7.27 (m, 8H), 7.09â7.07 (m, 1H), 7.01â6.95 (m, 3H), 4.58â4.56 (m, 2H), 3.85â3.70 (m, 3H), 1.98â1.96 (m, 2H). MS (EI) for C<sub>22</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>, found 363.0 (MH<sup>+</sup>).</div><div class="NLM_p">To a flask charged with 2-amino-3-benzyloxy-<i>N</i>-(4-phenoxyphenyl)propanamide (rac-<b>41</b>) (150 mg, 0.420 mmol) were added 2-(<i>N</i>-methylbenzamido)acetic acid (97 mg, 0.50 mmol), HATU (188 mg, 0.500 mmol), DMF (1 mL), and <i>N</i>,<i>N</i>-diisopropylethylamine (370 Î¼L, 2.10 mmol), and the mixture was stirred at room temperature for 18 h. The reaction mixture was partitioned between ethyl acetate and water. The aqueous layer was separated and extracted with ethyl acetate. The combined organic layer was washed with 5% lithium chloride (3Ã), 1 N sodium bicarbonate (2Ã), water (2Ã), then concentrated in vacuo. Product was purified from the residue by reverse phase HPLC. The purified product was taken up into methanol and the solution was neutralized with basic resin, filtered, and concentrated in vacuo to provide <i>N</i>-(2-(3-(benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-ylamino)-2-oxoethyl)-<i>N</i>-methylbenzamide (<b>1</b>) (32 mg, 14% yield) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.80 (s, 1H), 7.63â7.30 (m, 13H), 7.11â6.92 (m, 5H), 4.74â4.71 (m, 1H), 4.61â4.59 (m, 2H), 4.28â4.15 (m, 1H), 4.10â4.00 (m, 1H), 3.73â3.67 (m, 2H), 3.17 (s, 3H). MS (EI) for C<sub>32</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>, found 538.0 (MH<sup>+</sup>).</div><div class="NLM_p last">Compounds <b>2</b>â<b>24</b>, <b>27</b>, and <b>28</b> were prepared according to a similar procedure as described for the synthesis of compound <b>1.</b></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (<i>R</i>)-<i>N</i>-(2-(3-(Benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-ylamino)-2-oxoethyl)-<i>N</i>-methylbenzamide (<b>2</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.80 (s, 1H), 7.63â7.30 (m, 13H), 7.11â6.92 (m, 5H), 4.74â4.71 (m, 1H), 4.61â4.59 (m, 2H), 4.28â4.15 (m, 1H), 4.10â4.00 (m, 1H), 3.73â3.67 (m, 2H), 3.17 (s, 3H). MS (EI) for C<sub>32</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>, found 538.0 (MH<sup>+</sup>).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (<i>S</i>)-<i>N</i>-(2-(3-(Benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-ylamino)-2-oxoethyl)-<i>N</i>-methylbenzamide (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.80 (s, 1H), 7.63â7.30 (m, 13H), 7.11â6.92 (m, 5H), 4.73â4.72 (m, 1H), 4.61â4.59 (m, 2H), 4.28â4.15 (m, 1H), 4.10â4.00 (m, 1H), 3.72â3.70 (m, 2H), 3.17 (s, 3H). MS (EI) for C<sub>32</sub>H<sub>31</sub>N<sub>3</sub>O<sub>5</sub>, found 538.0 (MH<sup>+</sup>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>N</i>-(3-(Benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-yl)-5-oxo-5-(thiophen-2-yl)pentanamide (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.19 (s, 1H), 8.27 (d, <i>J</i> = 7.8 Hz, 1H), 7.98 (dd, <i>J</i> = 4.9, 1.1 Hz, 1H), 7.90 (dd, <i>J</i> = 3.8, 1.1 Hz, 1H), 7.70â7.50 (m, 2H), 7.41â7.32 (m, 2H), 7.33â7.23 (m, 5H), 7.20 (dd, <i>J</i> = 4.9, 3.8 Hz, 1H), 7.10 (tt, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.04â6.90 (m, 4H), 4.72 (q, <i>J</i> = 6.2 Hz, 1H), 4.52 (s, 2H), 3.72â3.57 (m, 2H), 2.96 (dd, <i>J</i> = 7.7, 5.7 Hz, 2H), 2.26 (t, <i>J</i> = 7.4 Hz, 2H), 1.95â1.74 (m, 2H). MS (EI) for C<sub>31</sub>H<sub>30</sub>N<sub>2</sub>O<sub>5</sub>S, found 543.7 (MH<sup>+</sup>).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-(3-(Benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-yl)cyclopropanecarboxamide (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.75â7.34 (m, 9H), 7.10â7.06 (m, 1 H), 6.98â6.95 (m, 4H), 4.89â4.87 (m, 1H), 4.70â4.62 (m 2H), 4.16â4.14 (m, 1H), 3.75â3.70 (m, 1H), 1.14â0.60 (m, 5H). MS (EI) for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>, found 431.5 (MH<sup>+</sup>).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>S</i>)-<i>N</i>-(3-(Benzyloxy)-1-oxo-1-(4-phenoxyphenylamino)propan-2-yl)-1<i>H</i>-imidazole-5-carboxamide (<b>6</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.54 (s, 1H), 8.52 (s, 1H), 7.98 (d, <i>J</i> = 7.5 Hz, 1H), 7.73 (s, 1H), 7.65 (s, 1H), 7.47â7.43 (m, 2H), 7.35â7.31 (m, 6H), 7.10â7.06 (m, 1 H), 6.99â6.96 (m, 4H), 4.91â4.88 (m, 1H), 4.69 (d, <i>J</i> = 11.8 Hz, 1H), 4.62 (d, <i>J</i> = 11.8 Hz, 1H), 4.13 (dd, <i>J</i> = 9.3, 4.3 Hz, 1H), 3.78 (dd, <i>J</i> = 9.4, 6.7 Hz, 1H). MS (EI) for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>, found 456.9 (MH<sup>+</sup>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-phenoxyphenyl)propanamide (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.23 (s, 1H), 7.53â7.40 (m, 4H), 7.35â7.27 (m, 6H) 7.08 (t, <i>J</i> = 8.0 Hz, 1H), 7.00â6.92 (m, 4H), 6.87 (s, 1H), 4.78.4.75 (m, 1H), 4.60 (d, <i>J</i> = 11.8 Hz, 1H), 4.52 (d, <i>J</i> = 11.8 Hz, 1H), 4.18 (dd, <i>J</i> = 9.3, 3.7 Hz, 1H), 3.66 (dd, <i>J</i> = 9.4, 5.8 Hz, 1H), 3.61 (d, <i>J</i> = 3.8 Hz, 2H). MS (EI) for C<sub>27</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>, found 471.0 (MH<sup>+</sup>).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>S</i>)-3-(Benzyloxy)-2-(2-(1-methyl-1<i>H</i>-imidazol-4-yl)acetamido)-<i>N</i>-(4-phenoxyphenyl)propanamide (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.25 (s, 1H), 7.51â7.34 (m, 3H), 7.35â7.30 (m, 7H) 7.10â7.09 (m, 1H), 6.99â6.96 (m, 4H), 6.79 (s, 1H), 4.79â4.75 (m, 1H), 4.63 (d, <i>J</i> = 11.8 Hz, 1H), 4.53 (d, <i>J</i> = 11.8 Hz, 1H), 4.14 (dd, <i>J</i> = 9.3, 3.5 Hz, 1H), 3.68â3.65 (m, 1H), 3.64 (s, 3H), 3.59 (d, <i>J</i> = 3.2 Hz, 2H). MS (EI) for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>, found 485.3 (MH<sup>+</sup>).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>S</i>)-3-(Benzyloxy)-2-(2-(2,5-dichlorophenyl)acetamido)-<i>N</i>-(4-phenoxyphenyl)propanamide (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.23 (s, 1H), 8.61 (d, <i>J</i> = 7.9 Hz, 1H), 7.63 (d, <i>J</i> = 9.0 Hz, 2H), 7.50 (d, <i>J</i> = 2.6 Hz, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 1H), 7.41â7.24 (m, 8H), 7.14â7.06 (m, 1H), 7.02 (d, <i>J</i> = 9.0 Hz, 2H), 6.97 (d, <i>J</i> = 7.7 Hz, 2H), 4.74 (dd, <i>J</i> = 13.9, 6.1 Hz, 1H), 4.54 (s, 2H), 3.73 (s, 2H), 3.71â3.65 (m, 2H). MS (EI) for C<sub>30</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>, found 549.3 (MH<sup>+</sup>).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-3-(Benzyloxy)-2-(2-(2-fluorophenyl)acetamido)-<i>N</i>-(4-phenoxyphenyl)propanamide (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.43 (s, 1H), 7.40â7.22 (m, 11H), 7.18â7.04 (m, 3H), 7.01â6.89 (m, 3H), 6.60 (d, <i>J</i> = 6.6 Hz, 1H), 4.76â4.68 (m, 1H), 4.64â4.47 (m, 2H) 4.03â3.95 (m, 1H), 3.66 (s, 2H), 3.61â3.54 (m, 1H). MS (EI) for C<sub>30</sub>H<sub>27</sub>FN<sub>2</sub>O<sub>4</sub>, found 498.9 (MH<sup>+</sup>).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(3-chloro-4-phenoxyphenyl)propanamide (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.41 (s, 1H), 8.45 (d, <i>J</i> = 10.0 Hz, 1H), 7.95 (s, 1H), 7.59 (s, 1H), 7.49 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.36â7.25 (m, 7H), 7.13 (d, <i>J</i> = 8.9 Hz, 1H), 7.09â7.06 (m, 1H), 6.89 (d, <i>J</i> = 7.7 Hz, 2H), 4.68â4.61 (m, 1H), 4.50 (s, 2H), 3.73â3.32 (m, 4H). MS (EI) for C<sub>27</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>4</sub>, found 504.9 (MH<sup>+</sup>).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(4-chlorophenoxy)phenyl)propanamide (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.95 (br s, 1H), 10.28 (s, 1H), 8.45 (d, <i>J</i> = 7.4 Hz, 1H), 7.66â7.63 (m, 3H), 7.43â7.39 (m, 2H), 7.33â7.25 (m, 4H), 7.05â6.98 (m, 5H), 4.72â4.65 (m, 1H), 4.51 (s, 2H), 3.73â3.63 (m, 2H), 3.54â3.40 (m, 2H). MS (EI) for C<sub>27</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>4</sub>, found 505.0 (MH<sup>+</sup>).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(3-chlorophenoxy)phenyl)propanamide (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.32 (s, 1H), 8.48 (d, <i>J</i> = 7.8 Hz, 1H), 7.68 (d, <i>J</i> = 9.0 Hz, 2H), 7.60 (s, 1H), 7.41â7.36 (t, <i>J</i> = 8.2 Hz, 1H), 7.34â7.25 (m, 5H), 7.17â7.15 (dd, <i>J</i> = 7.6, 2.2 Hz, 1H), 7.09â7.07 (d, <i>J</i> = 9.0 Hz, 2H), 7.02â6.98 (m, 1H), 6.94â6.91 (m, 2H), 4.71â4.66 (m, 1H), 4.52 (s, 2H), 3.73â3.64 (m, 2H), 3.52â3.39 (m, 2H). MS (EI) for C<sub>27</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>4</sub>, found 505.0 (MH<sup>+</sup>).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(2-chlorophenoxy)phenyl)propanamide (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.95 (s, 1H), 10.26 (s, 1H), 8.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.78â7.45 (m, 4H), 7.44â7.23 (m, 6H), 7.23â7.11 (m, 1H), 7.11â6.85 (m, 4H), 4.77â4.58 (m, 1H), 4.51 (s, 2H), 3.77â3.40 (m, 4H). MS (EI) for C<sub>27</sub>H<sub>25</sub>ClN<sub>4</sub>O<sub>4</sub>, found 505.0 (MH<sup>+</sup>).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)propanamide (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.94 (s, 1H), 10.23 (s, 1H), 8.43 (d, <i>J</i> = 8.6 Hz, 1H), 7.63â7.61 (m, 2H), 7.31â7.14 (m, 9H), 7.04â6.94 (m, 4H), 4.70â4.64 (m, 1H), 4.51 (s, 2H), 3.73â3.63 (m, 2H), 3.54â3.25 (m, 2H). MS (EI) for C<sub>27</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>, found 489.3 (MH<sup>+</sup>).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(cyclohexyloxy)phenyl)propanamide (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.95 (s, 1H), 7.70â7.50 (m, 2H), 7.37â7.25 (m, 7H), 6.96â6.87 (m, 3H), 4.79â4.73 (m, 1H), 4.64â4.61 (m, 2H), 4.17â4.10 (m, 2H), 3.68â3.59 (m, 3H), 1.80â1.20 (m, 10H). MS (EI) for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>, found 477.0 (MH<sup>+</sup>).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(benzyloxy)phenyl)propanamide (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.55 (s, 1H), 7.44â7.37 (m, 6H), 7.35â7.26 (m, 6H), 6.94â6.90 (m, 3H), 5.05 (s, 2H), 4.71 (dd, <i>J</i> = 5.0, 4.6 Hz, 1H), 4.58 (d, <i>J</i> = 11.8 Hz, 1H), 4.51 (d, <i>J</i> = 11.8 Hz, 1H), 3.98 (dd, <i>J</i> = 9.2, 3.9 Hz, 1H), 3.66 (dd, <i>J</i> = 9.4, 5.6 Hz, 1H), 3.60 (s, 2H). MS (EI) for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>, found 485.2 (MH<sup>+</sup>).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(dibenzo[<i>b</i>,<i>d</i>]furan-2-yl)propanamide (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.96 (s, 1H), 10.54 (s, 1H), 8.48 (d, <i>J</i> = 7.9 Hz, 1H), 8.17 (d, <i>J</i> = 1.5 Hz, 1H), 8.07 (dd, <i>J</i> = 8.0, 2.5 Hz, 2H), 7.68 (d, <i>J</i> = 8.2 Hz, 1H), 7.61 (s, 1H), 7.52â7.45 (m, 2H), 7.40 (s, 1H), 7.32â7.21 (m, 4H), 6.93 (s, 1H), 4.75 (dd, <i>J</i> = 11.4, 6.1 Hz, 1H), 4.52 (s, 2H), 3.88â3.62 (m, 2H), 3.52â3.41 (m, 2H). MS (EI) for C<sub>27</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>, found 469.0 (MH<sup>+</sup>).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-benzylphenyl)propanamide (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 11.95 (s, 1H), 10.14 (s, 1H), 8.39 (d, <i>J</i> = 7.9 Hz, 1H), 7.61 (s, 1H), 7.52 (d, <i>J</i> = 14.1 Hz, 1H), 7.30â7.15 (m, 11H), 6.96 (s, 1H), 4.71â4.64 (m, 1H), 4.49 (s, 2H), 3.89 (s, 2H), 3.71â3.61 (m, 2H), 3.51â3.32 (m, 2H). MS (EI) for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>, found 469.3 (MH<sup>+</sup>).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(4-(phenylamino)phenyl)propanamide (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.08 (s, 1H), 8.39 (d, <i>J</i> = 10.4 Hz, 1H), 8.08 (s, 1H), 7.62 (s, 1H), 7.48 (d, <i>J</i> = 7.5 Hz, 2H), 7.43â7.26 (m, 4H), 7.21 (dd, <i>J</i> = 19.4, 10.6 Hz, 2H), 7.10â6.93 (m, 4H), 6.77 (d, <i>J</i> = 8.1 Hz, 1H), 4.81â4.57 (m, 1H), 4.51 (s, 1H), 3.82â3.53 (m, 2H), 3.54â3.36 (m, 3H). MS (EI) for C<sub>27</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub>, found 470.3 (MH<sup>+</sup>).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-(biphenyl-4-yl)propanamide (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.97 (s, 1H), 10.31 (s, 1H), 8.46 (d, <i>J</i> = 7.8 Hz, 1H), 7.81â7.57 (m, 7H), 7.45 (t, <i>J</i> = 7.7 Hz, 2H), 7.37â7.15 (m, 6H), 4.82â4.62 (m, 1H), 4.50 (s, 2H), 3.81â3.53 (m, 2H), 3.53â3.36 (m, 2H). MS (EI) for C<sub>27</sub>H<sub>26</sub>N<sub>4</sub>O<sub>3</sub>, found 455.0 (MH<sup>+</sup>).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-<i>N</i>-(4-phenoxyphenyl)-5-phenylpentanamide (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.17 (s, 1H), 7.54 (d, <i>J</i> = 7.9 Hz, 1H), 7.48 (s, 1H), 7.46â7.39 (m, 2H), 7.35â7.20 (m, 4H), 7.20â7.01 (m, 4H), 6.95â6.88 (m, 3H), 6.81 (s, 1H), 4.60 (dd, <i>J</i> = 13.8, 7.6 Hz, 1H), 3.66â3.42 (m, 2H), 2.71â2.50 (m, 2H), 2.08â1.92 (m, 1H), 1.87â1.61 (m, 3H). MS (EI) for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>, found 469.5 (MH<sup>+</sup>).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-<i>N</i>-(4-(4-chlorophenoxy)phenyl)propanamide (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.94 (s, 1H), 10.12 (s, 1H), 8.37 (d, <i>J</i> = 7.3 Hz, 1H), 7.72â7.55 (m, 3H), 7.48â7.33 (m, 2H), 7.06â7.01 (m, 2H), 7.01â6.95 (m, 2H), 6.90 (s, 1H), 4.53â4.22 (m, 1H), 3.47â4.37 (m, 2H), 1.32 (s, 3H). MS (EI) for C<sub>20</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>3</sub>, found 455.0 (MH<sup>+</sup>).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-<i>N</i>-(4-(4-chlorophenoxy)phenyl)-3-phenylpropanamide (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.98 (s, 1H), 10.25 (s, 1H), 8.43 (d, <i>J</i> = 8.1 Hz, 1H), 7.68â7.49 (m, 3H), 7.49â7.31 (m, 2H), 7.35â7.13 (m, 5H), 7.09â6.87 (m, 4H), 6.80 (s, 1H), 4.65 (td, <i>J</i> = 9.0, 5.1 Hz, 1H), 3.40 (d, <i>J</i> = 15.5 Hz, 1H), 3.33 (d, <i>J</i> = 15.5 Hz, 1H), 3.07 (dd, <i>J</i> = 27.9, 14.0 Hz, 1H), 2.88 (dd, <i>J</i> = 13.7, 9.3 Hz, 1H). MS (EI) for C<sub>26</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>3</sub>, found 475.9 (MH<sup>+</sup>).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)-<i>N</i>-methylacetamido)-3-(benzyloxy)-<i>N</i>-(4-phenoxyphenyl)propanamide (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, mixture of rotamers observed) Î´ 12.30â11.90 (m, 1H), 10.20 (s,1H), 7.94â7.09 (m, 16H), 5.35â5.30 (m, 1H), 4.62â4.48 (m, 2H), 4.04â3.59 (m, 1H), 3.41 (d, <i>J</i> = 14.4 Hz, 1H), 3.08 (s, 3H), 2.70 (s, 2H). MS (EI) for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub>, found 485.2 (MH<sup>+</sup>).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-2-(2-(1<i>H</i>-Imidazol-5-yl)acetamido)-3-(benzyloxy)-<i>N</i>-methyl-<i>N</i>-(4-phenoxyphenyl)propanamide (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.59â7.20 (m, 9H), 7.17 (t, <i>J</i> = 7.4 Hz, 1H), 7.12â6.74 (m, 5H), 6.76â6.07 (m, 1H), 4.80 (dd, <i>J</i> = 12.2, 4.9 Hz, 1H), 4.48 (d, <i>J</i> = 12.1 Hz, 1H), 4.31 (d, <i>J</i> = 12.1 Hz, 1H), 3.67â3.47 (m, 3H), 3.42 (dd, <i>J</i> = 9.7, 5.2 Hz, 1H), 3.22 (s, 3H). MS (EI) for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>, found 485.0 (MH<sup>+</sup>).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-<i>N</i>-(2-(Benzyloxy)-1-(5-(4-fluorophenoxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)ethyl)-2-(1<i>H</i>-imidazol-5-yl)acetamide (<b>29</b>)</h3><div class="NLM_p">A mixture of 5-chloro-2-nitroaniline (345 mg, 2.00 mmol), 4-fluorophenol (224 mg, 2.00 mmol), K<sub>2</sub>CO<sub>3</sub> (549 mg, 4.00 mmol), and DMF (8 mL) was stirred at 120 Â°C for 24 h. After the mixture was cooled, water was added and the mixture was extracted with ethyl acetate (4Ã). The combined organic layers were dried over anhydrous magnesium sulfate, concentrated, and purified by flash chromatography (hexanes/ethyl acetate (6:1)) to give 5-(4-fluorophenoxy)-2-nitroaniline (510 mg, quant) as a yellow powder.</div><div class="NLM_p">A mixture of 5-(4-fluorophenoxy)-2-nitroaniline (410 mg, 1.65 mmol), ammonium formate (520 mg, 8.26 mmol), 10% Pd/C (123 mg, 0.116 mmol), and methanol (10 mL) was stirred at room temperature for 30 min. After filtration, the filtrate was concentrated and the residue was purified by flash chromatography (hexanes/ethyl acetate (2:3 to 1:2)) to give <b>43</b> (370 mg, quant) as a brown oil.</div><div class="NLM_p">To a stirred solution of <b>43</b> (370 mg, 1.70 mmol), <b>39</b> (550 mg, 1.86 mmol), and DMF (4 mL) were added <i>N</i>,<i>N</i>-diisopropylethylamine (0.880 mL, 5.10 mmol) and HATU (750 mg, 2.00 mmol) at room temperature. After the mixture was stirred for 1 h, saturated sodium bicarbonate was added and the resulting solution was extracted with ethyl acetate (4Ã). The combined organic layers were dried over anhydrous magnesium sulfate, concentrated, and purified by flash chromatography (hexanes/ethyl acetate (3:1 to 2:1)) to give (<i>S</i>)-<i>tert</i>-butyl 1-(2-amino-4-(4-fluorophenoxy)phenylamino)-3-(benzyloxy)-1-oxopropan-2-ylcarbamate (610 mg, 72%) as a brown foam.</div><div class="NLM_p">A mixture of (<i>S</i>)-<i>tert</i>-butyl 1-(2-amino-4-(4-fluorophenoxy)phenylamino)-3-(benzyloxy)-1-oxopropan-2-ylcarbamate (610 mg, 1.23 mmol) and AcOH (6 mL) was stirred at 60 Â°C for 1 h. After removal of acetic acid in vacuo, HCl (4 mL, 4 N in dioxane) was added and the resulting solution was stirred at room temperature for 30 min. After concentration, the residue was purified by reverse phase HPLC to give (<i>R</i>)-2-(benzyloxy)-1-(5-(4-fluorophenoxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)ethanamine (250 mg, 54%) as a pale yellow foam.</div><div class="NLM_p last">To a stirred solution of (<i>R</i>)-2-(benzyloxy)-1-(5-(4-fluorophenoxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)ethanamine (150 mg, 0.397 mmol), 4-imidazoleacetic acid hydrochloride (84.0 mg, 0.517 mmol), and DMF (1.5 mL) were added <i>N</i>,<i>N</i>-diisopropylethylamine (0.350 mL, 1.99 mmol) and HATU (226 mg, 0.596 mmol) at room temperature. After the mixture was stirred for 30 min, saturated sodium bicarbonate was added and the resulting solution was extracted with ethyl acetate (4Ã). The combined organic layers were dried over anhydrous magnesium sulfate, concentrated, and purified by reverse phase HPLC to give <b>29</b> (75 mg, 39%) as a white powder after lyophilization. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 12.43 (br s, 1H), 8.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.77 (s, 1H), 7.56 (d, <i>J</i> = 8.6 Hz, 1H), 7.33â7.25 (m, 5H), 7.20â7.16 (m, 3H), 7.00â6.96 (m, 3H), 6.89 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 5.35â5.30 (m, 1H), 4.52 (s, 2H), 3.93 (dd, <i>J</i> = 9.8, 5.1 Hz, 1H), 3.86 (dd, <i>J</i> = 9.8, 7.0 Hz, 1H), 3.55 (d, <i>J</i> = 15.2 Hz, 1H), 3.48 (d, <i>J</i> = 15.2 Hz, 1H). MS (EI) for C<sub>27</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>3</sub>, found 486.2 (MH<sup>+</sup>).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-1-(2-(1<i>H</i>-Imidazol-5-yl)acetyl)-4-benzyl-<i>N</i>-(4-(4-fluorophenoxy)phenyl)piperazine-2-carboxamide (<b>30</b>)</h3><div class="NLM_p">A flask was charged with <b>44</b> (1.00 g, 2.74 mmol), 4-(4-fluorophenoxy)aniline (558 mg, 2.75 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (3.00 mL, 17.3 mmol), HATU (1.15 g, 3.03 mmol), and DMF (8 mL). The reaction mixture was stirred at room temperature for 20 min, at which time it was quenched with saturated sodium bicarbonate and extracted with ethyl acetate. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate, filtered, and concentrated to provide (<i>S</i>)-4-benzyl 1-<i>tert</i>-butyl 2-(4-(4-fluorophenoxy)phenylcarbamoyl)piperazine-1,4-dicarboxylate (1.46 g, quant) as an off-white solid.</div><div class="NLM_p">A flask was charged with (<i>S</i>)-4-benzyl 1-<i>tert</i>-butyl 2-(4-(4-fluorophenoxy)phenylcarbamoyl)piperazine-1,4-dicarboxylate (1.46 g, 2.75 mmol) and HCl (10 mL, 4 N in dioxane). The mixture was stirred at room temperature for 1 h, at which time it was quenched with saturated sodium bicarbonate and extracted with ethyl acetate. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate, filtered, and concentrated to provide (<i>S</i>)-benzyl 3-(4-(4-fluorophenoxy)phenylcarbamoyl)piperazine-1-carboxylate (1.08 g, 88%) as an off-white solid.</div><div class="NLM_p">A flask was charged with (<i>S</i>)-benzyl 3-(4-(4-fluorophenoxy)phenylcarbamoyl)piperazine-1-carboxylate (1.08 g, 2.41 mmol), 4-imidazoleacetic acid hydrochloride (392 mg, 2.41 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (1.0 mL, 5.8 mmol), HATU (1.01 g, 2.65 mmol), and DMF (5 mL). The reaction mixture was stirred at room temperature for 20 min, at which time it was quenched with saturated sodium bicarbonate and extracted with ethyl acetate. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue was purified by reverse phase HPLC to provide<b>45</b> (0.80 g, 67% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 10.27 (s, 1H), 9.18 (s, 1H), 7.60â7.49 (m, 3H), 7.47â7.21 (m, 5H), 7.06â6.91 (m, 6H), 5.45 (s, 1 H), 5.17 (s, 2H), 5.09â5.00 (m, 2H), 4.09â3.97 (m, 2H), 3.81â3.73 (m, 2H), 3.46â3.37 (m, 1H), 3.17 (dd, <i>J</i> = 12.6, 4.3 Hz, 1H), 3.13â3.00 (m, 1H). MS (EI) for C<sub>30</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>5</sub>, found</div><div class="NLM_p">A flask was charged with <b>45</b> (0.80 g, 1.4 mmol), methanol (10 mL), and Pd/C (10%, 100 mg). The mixture was stirred under a hydrogen atmosphere (balloon) for 14 h, at which time it was exposed to air, filtered through Celite, and concentrated. The residue was purified by reverse phase HPLC to yield (<i>S</i>)-1-(2-(1<i>H</i>-imidazol-5-yl)acetyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)piperazine-2-carboxamide (0.50 g, 83% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 10.02 (s, 1H), 9.20 (s, 1H), 7.63â7.56 (m, 2H), 7.52 (s, 1H), 7.05â6.93 (m, 6H), 5.34 (s, 1 H), 4.05â4.00 (m, 1H), 3.94â3.86 (m, 1H), 3.78â3.71 (m, 2H), 3.28â3.20 (m, 1H), 3.00â2.94 (m, 1H), 2.89â2.74 (m, 2H), 2.61â2.53 (m, 1H). MS (EI) for C<sub>22</sub>H<sub>22</sub>FN<sub>5</sub>O<sub>3</sub>, found 424.2 (MH<sup>+</sup>).</div><div class="NLM_p last">A flask was charged with (<i>S</i>)-1-(2-(1<i>H</i>-imidazol-5-yl)acetyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)piperazine-2-carboxamide (107 mg, 0.252 mmol), benzaldehyde (0.154 mL, 1.51 mmol), methanol (10 mL), and NaBH(OAc)<sub>3</sub> (534 mg, 2.52 mmol). The reaction mixture was stirred at room temperature for 30 min, at which time it was diluted with water and washed with DCM. The aqueous layer was then basified with 2 N NaOH, extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The product (<b>30</b>) was yielded as an off-white solid (41 mg, 32% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 10.23 (s, 1H), 7.63â7.18 (m, 8H), 7.02â6.82 (m, 6H), 5.42 (s, 1 H), 4.02â3.90 (m, 1H), 3.88â3.80 (m, 1H), 3.78â3.61 (m, 2H), 3.58â3.34 (m, 2H), 3.08â2.97 (m, 1H), 2.78â2.64 (m 1H), 2.28â2.18 (m, 1H), 2.11â2.00 (m, 1H). MS (EI) for C<sub>29</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>3</sub>, found 514.3 (MH<sup>+</sup>).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>S</i>,4<i>R</i>)-1-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (<b>37</b>)</h3><div class="NLM_p">To a solution of <span class="smallcaps smallerCapital">l</span>-pyroglutamic acid (<b>46</b>) (20.00 g, 154.9 mmol) in <i>tert</i>-butyl acetate (260 mL, 1.93 mol) at room temperature was added 70% aqueous perchloric acid (5 mL). The mixture was stirred for 18 h in a 500 mL round-bottom flask sealed with a rubber septum, then poured carefully into saturated sodium bicarbonate. The mixture was extracted with ethyl acetate (2Ã), dried over sodium sulfate, and concentrated in vacuo. The crude product solidified under high vacuum. The solid was treated with a mixture of hexanes/ether (10:1), filtered, and dried to give <i>tert</i>-butyl <span class="smallcaps smallerCapital">l</span>-pyroglutamate (21.65 g, 75% yield) as a colorless solid.</div><div class="NLM_p">The colorless solid obtained above (21.65 g, 116.9 mmol) was dissolved in acetonitrile (300 mL) with <i>N</i>,<i>N</i>-dimethylaminopyridine (1.29 g, 10.6 mmol) and cooled to 0 Â°C. A solution of di-<i>tert</i>-butylcarbonate (33.20 g, 152.0 mmol) in acetonitrile (30 mL) was added slowly over 5 min. After 30 min the cooling bath was removed and the mixture was stirred at room temperature for 48 h. The mixture was concentrated in vacuo, and the residue was dissolved in ether (200 mL) and hexanes (200 mL). The organic phase was washed with saturated sodium bicarbonate (2Ã), saturated sodium chloride and dried over anhydrous sodium sulfate. The solvent was removed in vacuo and the residue was passed through a short column of silica gel (eluted with hexanes/ethyl acetate, 4:1) to give a light yellow oil that solidified on standing. The solid thus obtained was treated with hexanes, filtered, and dried to give (<i>S</i>)-di-<i>tert</i>-butyl 5-oxopyrrolidine-1,2-dicarboxylate (24.22 g) as a pure colorless solid. The mother liquor was concentrated to give an additional crop (4.05 g) of colorless solid. The total yield of (<i>S</i>)-di-<i>tert</i>-butyl 5-oxopyrrolidine-1,2-dicarboxylate obtained in this manner was 85%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 4.50â4.46 (m, 1H), 2.67â2.56 (m, 1H), 2.52â2.43 (m, 1H), 2.35â2.23 (m, 1H), 2.04â1.96 (m, 1H), 1.51 (s, 9H), 1.49 (s, 9H).</div><div class="NLM_p">To a solution of (<i>S</i>)-di-<i>tert</i>-butyl 5-oxopyrrolidine-1,2-dicarboxylate (26.19 g, 91.79 mmol) in dry tetrahydrofuran (811 mL) at â78 Â°C was added a solution of lithium bis(trimethylsilyl)amide (1 M in hexanes, 100.8 mL, 100.8 mmol) dropwise over 1 h under nitrogen. Upon completion of addition, the mixture was stirred for an additional 2 h at â78 Â°C. Then a solution of 4-fluorobenzyl bromide (19.00 g, 100.8 mmol) in tetrahydrofuran (48 mL) was added over 10 min. The mixture was stirred at â78 Â°C for 2 h, quenched with saturated ammonium chloride, and extracted with ether (2Ã). The combined organic layers were washed with saturated sodium chloride, dried over anhydrous sodium sulfate, and concentrated in vacuo. The crude mixture was purified by recrystallization from hexanes to give <b>49</b> (18.30 g) as a colorless solid. The mother liquor was purified by flash column chromatography (hexanes/ethyl acetate, 4:1) and recrystallized from hexanes to give an additional crop (4.90 g) of the colorless solid. The total yield of <b>49</b> obtained in this manner was 65%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 7.14 (dd, <i>J</i> = 8.4, 5.2 Hz, 2H), 6.98 (t, <i>J</i> = 8.6 Hz, 2H), 4.35 (dd, <i>J</i> = 9.0, 2.2 Hz, 1H), 3.20 (dd, <i>J</i> = 14.2, 4.2 Hz, 1H), 2.92â2.84 (m, 1H), 2.71 (dd, <i>J</i> = 13.8, 9.0 Hz, 1H), 2.04â1.90 (m, 2H), 1.51 (s, 9H), 1.45 (s, 9H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) Î´ 174.6, 170.4, 163.2, 160.7, 149.5, 134.1, 134.1, 130.8, 130.7, 115.8, 159.6, 83.6, 82.6, 57.9, 43.6, 35.5, 28.2. MS (EI) for C<sub>21</sub>H<sub>28</sub>FNO<sub>5</sub>: (392.2, MH<sup>â</sup>). Mp: 99 Â°C.</div><div class="NLM_p">To a solution of <b>49</b> (23.20 g, 58.97 mmol) in dry tetrahydrofuran (200 mL) at â78 Â°C was added a 1 M solution of lithium triethylborohydride in tetrahydrofuran (70.8 mL, 70.8 mmol) dropwise. After 30 min, the cooling bath was removed and saturated sodium bicarbonate was added. The reaction mixture was immersed in an iceâwater bath, and 30% aqueous hydrogen peroxide (10 mL) was added. The mixture was stirred for 20 min at 0 Â°C, then concentrated in vacuo to remove the tetrahydrofuran. The residue was diluted with water and extracted with dichloromethane (3Ã). The combined organic extracts were dried over sodium sulfate and concentrated in vacuo. The residue was dissolved in dichloromethane (200 mL) and triethylsilane (9.14 mL, 59.0 mmol). The solution was cooled to â78 Â°C, and to this mixture was added boron trifluoride etherate (7.97 mL, 62.9 mmol) dropwise. The mixture was stirred at â78 Â°C for 30 min, at which time additional triethylsilane (9.14 mL, 59.0 mmol) and boron trifluoride etherate (7.97 mL, 62.9 mmol) were added. After the mixture was stirred at â78 Â°C for 2 h, the cooling bath was removed and saturated sodium bicarbonate was added. After 5 min, the mixture was extracted with dichloromethane (3Ã) and the combined organic extracts were dried over sodium sulfate and concentrated in vacuo to give (2<i>S</i>,4<i>R</i>)-di-<i>tert</i>-butyl 4-(4-fluorobenzyl)pyrrolidine-1,2-dicarboxylate. This material was dissolved in dichloromethane (50 mL), diluted with trifluoroacetic acid (50 mL), and stirred at room temperature for 5 h. The solution was concentrated in vacuo and dried under high vacuum to give (2<i>S,</i>4<i>R</i>)-4-(4-fluorobenzyl)pyrrolidine-2-carboxylic acid (24.05 g, 90%, trifluoroacetate salt) as a light yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (br s, 1H), 8.77 (br s, 1H), 7.24 (dd, <i>J</i> = 8.4, 5.6 Hz, 2H), 7.10 (t, <i>J</i> = 8.8 Hz, 2H), 4.49â4.41 (m, 1H), 3.34â3.24 (m, 1H), 2.91â2.81 (m, 1H), 2.70â2.64 (m, 2H), 2.51â2.42 (m, 1H), 2.11â1.93 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 171.2, 162.8, 160.4, 159.5, 159.2, 136.4, 131.2, 131.1, 115.9, 115.7, 58.9, 50.2, 39.1, 37.0, 33.8. MS (EI) for C<sub>12</sub>H<sub>14</sub>FNO<sub>2</sub>: (224.1, MH<sup>+</sup>).</div><div class="NLM_p">To a solution of the trifluoroacetate salt of (2<i>S</i>,4<i>R</i>)-4-(4-fluorobenzyl)pyrrolidine-2-carboxylic acid (24.05 g, 58.97 mmol) in dioxane (150 mL), acetonitrile (250 mL), and <i>N</i>,<i>N</i>-diisopropylethylamine (27.6 mL) at room temperature was added a solution of di-<i>tert</i>-butyl carbonate (18.67 g, 85.70 mmol) in acetonitrile (50 mL). After being stirred at room temperature for 24 h, the mixture was concentrated in vacuo, dissolved in saturated sodium bicarbonate, and washed with ether (3Ã). The aqueous layer was acidified with citric acid to pH 4, then extracted with dichloromethane (3Ã). The combined organic layers were dried over sodium sulfate and concentrated in vacuo to give (2<i>S</i>,4<i>R</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-(4-fluorobenzyl)pyrrolidine-2-carboxylic acid (19.02 g, 100% yield) as a yellow oil that solidified on standing. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 12.56 (br s, 1H), 7.23â7.19 (m, 2H), 7.08 (t, <i>J</i> = 8.6 Hz, 2H), 4.13â4.09 (m, 1H), 3.37 (dd, <i>J</i> = 10.2, 7.4 Hz, 1H), 2.95 (dd, <i>J</i> = 14.2, 8.2 Hz, 1H), 2.60 (d, <i>J</i> = 7.6 Hz, 2H), 2.44â2.34 (m, 1H), 1.97â1.78 (m, 2H), 1.35 (s, 4H), 1.30 (s, 5H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 174.8, 174.4, 162.6, 160.2, 154.1, 153.7, 137.0, 131.1, 131.0, 115.8, 115.6, 79.4, 79.3, 59.2, 59.0, 51.9, 51.6, 38.6, 37.7, 36.1, 35.4, 28.8, 28.6. MS (EI) for C<sub>17</sub>H<sub>22</sub>FNO<sub>4</sub>: (322.2, MH<sup>â</sup>). Mp: 108 Â°C. Anal. Calcd for C<sub>17</sub>H<sub>22</sub>FNO<sub>4</sub>: C, 63.14; H, 6.86; N, 4.33. Found: C, 63.02; H, 7.05; N, 4.26.</div><div class="NLM_p">A mixture of (2<i>S</i>,4<i>R</i>)-1-(<i>tert</i>-butoxycarbonyl)-4-(4-fluorobenzyl)pyrrolidine-2-carboxylic acid (27.50 g, 85.04 mmol), 4-fluorophenoxyaniline (18.15 g, 89.32 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (23 mL), and HATU (34.00 g, 89.42 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (80 mL) was stirred at room temperature for 2 h. The mixture was diluted with ethyl acetate, washed with saturated sodium bicarbonate, washed with saturated sodium chloride, dried over sodium sulfate, and concentrated in vacuo. The crude product was purified by flash column chromatography (hexanes/ethyl acetate, 4:1) to give (2<i>S</i>,4<i>R</i>)-<i>tert</i>-butyl 4-(4-fluorobenzyl)-2-(4-(4-fluorophenoxy)phenylcarbamoyl)pyrrolidine-1-carboxylate (34.50 g, 80% yield) as a yellow oil.</div><div class="NLM_p">To a solution of (2<i>S</i>,4<i>R</i>)-<i>tert</i>-butyl 4-(4-fluorobenzyl)-2-(4-(4-fluorophenoxy)phenylcarbamoyl)pyrrolidine-1-carboxylate (34.50 g, 67.84 mmol) in dichloromethane (50 mL) was added trifluoroacetic acid (50 mL) at room temperature. The mixture was stirred at room temperature for 30 min and concentrated in vacuo. The residue was redissolved in dichloromethane (500 mL), washed with saturated sodium bicarbonate, dried over sodium sulfate, and concentrated in vacuo. The residue was triturated with ether (100 mL) and filtered to give <b>52</b> (23.65 g, 85% yield) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.98 (s, 1H), 7.66 (d, <i>J</i> = 9.2 Hz, 2H), 7.26â7.18 (m, 4H), 7.10 (t, <i>J</i> = 8.8 Hz, 2H), 7.02â6.96 (m, 2H), 6.95 (d, <i>J</i> = 8.8 Hz, 2H), 3.77 (dd, <i>J</i> = 9.2, 4.8 Hz, 1H), 3.23 (br s, 1H), 2.95 (dd, <i>J</i> = 10.0, 6.4 Hz, 1H), 2.63â2.59 (m, 2H), 2.51â2.50 (m, 1H), 2.27â2.16 (m, 1H), 1.91â1.74 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): Î´ 173.4, 162.9, 160.4, 160.0, 157.6, 153.7, 153.7, 153.6, 136.3, 136.3, 133.6, 130.2, 130.2, 121.0, 120.1, 120.0, 119.4, 116.6, 116.3, 115.6, 115.3, 60.6, 52.7, 40.7, 38.4, 37.0. MS (EI) for C<sub>24</sub>H<sub>22</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>: (409.2, MH<sup>+</sup>). Mp: 129 Â°C. Anal. Calcd for C<sub>24</sub>H<sub>22</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>: C, 70.57; H, 5.43; N, 6.86. Found: C, 70.60; H, 5.44; N, 6.83</div><div class="NLM_p">A mixture of <b>52</b> (23.65 g, 57.90 mmol), 2-(1<i>H</i>-1,2,3-triazol-1-yl)acetic acid (7.73 g, 60.8 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (15 mL), and HATU (23.50 g, 61.80 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (80 mL) was stirred at room temperature for 1 h. The mixture was diluted with ethyl acetate, washed with saturated sodium bicarbonate, 3 N aqueous hydrochloric acid (2Ã), saturated sodium bicarbonate, and 5% aqueous lithium chloride (2Ã). The organic phase was dried over sodium sulfate and concentrated in vacuo to give a colorless solid. The crude product was treated with a small amount of ethyl acetate and filtered to give <b>37</b> (23.87 g, 80% yield) as a colorless solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 8.96 (s, 1H), 7.78 (d, <i>J</i> = 11.2 Hz, 2H), 7.43 (d, <i>J</i> = 9.2 Hz, 2H), 7.16 (dd, <i>J</i> = 8.6, 5.0 Hz, 2H), 7.04â6.98 (m, 4H), 6.94â6.89 (m, 4H), 5.28 (d, <i>J</i> = 16.0 Hz, 1H), 5.14 (d, <i>J</i> = 16.4 Hz, 1H), 4.80 (d, <i>J</i> = 7.6 Hz, 1H), 3.68 (dd, <i>J</i> = 9.2, 8.0 Hz, 1H), 3.27 (t, <i>J</i> = 9.6 Hz, 1H), 3.02â2.92 (m, 1H), 2.88 (dd, <i>J</i> = 13.8, 6.6 Hz, 1H), 2.68 (dd, <i>J</i> = 14.0, 8.2 Hz, 1H), 2.61â2.56 (m, 1H), 1.75â1.66 (m, 1H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD): Î´ 171.0, 165.7, 163.1, 160.6, 160.1, 157.7, 154.2, 153.7, 153.6, 135.9, 135.9, 133.8, 133.2, 130.3, 130.2, 126.5, 121.9, 120.1, 120.0, 118.6, 116.2, 115.9, 115.2, 115.0, 61.1, 51.6, 51.2, 40.1, 37.5, 35.1. IR (KBr pellet): 3285, 2940, 1667, 1605, 1509, 1496, 1209 cm<sup>â1</sup>. Mp: 170 Â°C. MS (EI) C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>: 518.2 (MH<sup>+</sup>). High resolution MS: FAB MS using glycerol as matrix. Calculated for C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>: 518.20039. Found: 518.20038. Optical rotation: [Î±]<sub>D</sub> â83.7Â° (<i>c</i> 1.0244, EtOH, 25 Â°C). Anal. Calcd for C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>: C, 64.98; H, 4.87; N, 13.53. Found: C, 64.77; H, 4.80; N, 13.57.</div><div class="NLM_p last">Compounds <b>31</b>â<b>35</b> and <b>38</b> were prepared according to a similar procedure as described for the synthesis of compound <b>37.</b></div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (2<i>S</i>,4<i>R</i>)-1-(2-(1<i>H</i>-Imidazol-5-yl)acetyl)-4-benzyl-<i>N</i>-(4-phenoxyphenyl)pyrrolidine-2-carboxamide (<b>31</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (mixture of rotamers, 400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 12.28 (br s, 1H), 10.06 (s, 1H), 7.73â7.75 (m, 3H), 7.33â7.15 (m, 7H), 7.05â6.92 (m, 5H), 4.54â4.48 (m, 1H), 3.76â3.45 (m, 4H), 2.74â2.54 (m, 3H), 1.98â1.87 (m, 2H). MS (EI) for C<sub>29</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>3</sub>, found 499.0 (MH<sup>+</sup>).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (2<i>S</i>,4<i>S</i>)-1-(2-(1<i>H</i>-Imidazol-5-yl)acetyl)-<i>N</i>-(4-phenoxyphenyl)-4-phenylpyrrolidine-2-carboxamide (<b>32</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (mixture of rotamers, 400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 11.90 (s, 1H), 10.19 (s, 1H), 7.70â7.58 (m, 3H), 7.39â7.16 (m, 7H), 7.70â6.93 (m, 5H), 4.65â4.58 (m, 1H), 4.09 (t, <i>J</i> = 8.3 Hz, 1H), 3.75â3.44 (m, 4H), 2.41â2.22 (m, 2H). MS (EI) for C<sub>28</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>3</sub>, found 484.9 (MH<sup>+</sup>).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>S</i>,4<i>S</i>)-1-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)acetyl)-<i>N</i>-(4-phenoxyphenyl)-4-phenylpyrrolidine-2-carboxamide (<b>33</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 9.08 (s, 1H), 8.27 (s, 1H), 8.01 (s, 1H), 7.46 (d, <i>J</i> = 11.8 Hz, 2H), 7.40â7.37 (m 2H), 7.33â7.29 (m, 3H), 7.04â6.99 (m, 2H), 6.96â6.92 (m, 4H), 5.04 (d, <i>J</i> = 2.9 Hz, 2H), 4.96 (d, <i>J</i> = 7.7 Hz, 1H), 4.06 (t, <i>J</i> = 9.6 Hz, 1H), 3.96â3.86 (m, 1H), 3.61 (t, <i>J</i> = 10.0 Hz, 1H), 2.90 (dd, <i>J</i> = 12.3, 5.9 Hz 1H), 2.20â2.11 (m, 1H). MS (EI) for C<sub>27</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>3</sub>, found 486.2 (MH<sup>+</sup>).</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (2<i>S</i>,4<i>R</i>)-1-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)acetyl)-4-benzyl-<i>N</i>-(4-phenoxyphenyl)pyrrolidine-2-carboxamide (<b>34</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.99 (s, 1H), 8.43 (s, 1H), 7.95 (s, 1H), 7.55 (d, <i>J</i> = 9.0 Hz, 2H), 7.36â7.15 (m, 7H), 7.05â6.91 (m, 4H), 5.28 (d, <i>J</i> = 16.9 Hz, 1H), 5.20 (d, <i>J</i> = 16.9 Hz, 1H), 4.54â4.47 (m, 1H), 3.84â3.79 (m, 1H), 3.37â3.33 (m, 1H), 2.78â2.63 (m, 3H), 2.02â1.87 (m, 2H). MS (EI) for C<sub>28</sub>H<sub>26</sub>FN<sub>5</sub>O<sub>3</sub>, found 500.0 (MH<sup>+</sup>).</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2<i>S</i>,4<i>R</i>)-1-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (<b>35</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 10.00 (s, 1H), 8.43 (s, 1H), 7.95 (s, 1H), 7.57â7.54 (m, 2H), 7.35â7.08 (m, 6H), 7.05â6.90 (m, 4H), 5.27 (d, <i>J</i> = 16.0 Hz, 1H), 5.18 (d, <i>J</i> = 16.0 Hz, 1H), 4.56â4.47 (m, 1H), 3.87â3.74 (m, 1H), 3.36â3.22 (m, 1H), 2.79â2.62 (m, 3H), 2.04â1.89 (m, 2H). MS (EI) for C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>, found 519.9 (MH<sup>+</sup>).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (2<i>S</i>,4<i>R</i>)-1-(2-(2<i>H</i>-1,2,3-Triazol-2-yl)acetyl)-4-(4-fluorobenzyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (<b>38</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.97 (s, 1H), 8.43 (s, 1H), 7.80 (s, 1H), 7.58â7.51 (m, 2H), 7.34â7.07 (m, 6H), 7.04â6.90 (m, 4H), 5.51 (d, <i>J</i> = 16.7 Hz, 1H), 5.44 (d, <i>J</i> = 16.7 Hz, 1H), 4.53â4.46 (m, 1H), 3.85â3.76 (m, 1H), 3.36â3.32 (m, 1H), 2.77â2.61 (m, 3H), 2.03â1.86 (m, 2H). MS (EI) for C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>, found 519.7 (MH<sup>+</sup>).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (2<i>S</i>,4<i>S</i>)-1-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (<b>36</b>)</h3><div class="NLM_p">A flask was charged with <b>54</b> (2.10 g, 9.10 mmol), HATU (3.80 g, 10.0 mmol), 4-(4-fluorophenoxy)aniline (1.85 g, 9.09 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (4.8 mL, 27 mmol), and DMF (20 mL). The reaction mixture was stirred at room temperature for 30 min, at which time it was quenched with saturated sodium bicarbonate and extracted with ethyl acetate. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The crude mixture was used without further purification.</div><div class="NLM_p">The crude mixture was combined with HCl (20 mL, 4 N in dioxane) and stirred at room temperature for 1 h, at which time it was quenched with saturated sodium bicarbonate and extracted with ethyl acetate. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude mixture was triturated with ethyl acetate to provide (2<i>R</i>,4<i>R</i>)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)-4-hydroxypyrrolidine-2-carboxamide as an off-white solid (1.47 g, 4.65 mmol, 51% yield).</div><div class="NLM_p">A flask was charged with (2<i>R</i>,4<i>R</i>)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)-4-hydroxypyrrolidine-2-carboxamide (1.47 g, 4.65 mmol), 2-(1<i>H</i>-1,2,4-triazol-1-yl)acetic acid (591 mg, 4.65 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (3.0 mL, 17 mmol), HATU (1.90 g, 5.00 mmol), and DMF (10 mL). The reaction mixture was stirred at room temperature for 20 min, at which time it was quenched with saturated sodium bicarbonate and extracted with ethyl acetate. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue was triturated with ethyl acetate to provide <b>55</b> as an off-white solid (1.37 g, 3.25 mmol, 70% yield).</div><div class="NLM_p">To a flask charged with oxalyl chloride (0.165 mL, 1.89 mmol) and DCM (4 mL) at â78 Â°C was added DMSO (3.78 mmol, 0.268 mL) dropwise. The solution was stirred for 15 min before <b>55</b> (0.20 g, 0.47 mmol) in DCM (1 mL) was added via syringe. The reaction mixture was then stirred at 0 Â°C for 30 min before it was quenched with triethylamine (2.0 mL, 15 mmol). After the mixture was stirred for an additional 5 min, saturated ammonium chloride was added. The organic layer was purified directly by flash chromatography (ethyl acetate to ethyl acetate/methanol (9:1) + 1% NEt<sub>3</sub>) to provide the ketone (0.11 g, 0.25 mmol, 53% yield) as a colorless oil.</div><div class="NLM_p">To a flask charged with NaH (60% dispersion in oil, 124 mg, 3.10 mmol) and DMSO (2 mL) was added 4-fluorobenzyltriphenylphosphine chloride (1.00 g, 2.46 mmol) in DMSO (2 mL).The reaction mixture was stirred at 70 Â°C for 3 h, over which time it turned a dark red color. (<i>R</i>)-1-(2-(1<i>H</i>-1,2,4-Triazol-1-yl)acetyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)-4-oxopyrrolidine-2-carboxamide (0.11 g, 0.25 mmol) in DMSO (2 mL) was added. The reaction mixture was stirred for 16 h at 70 Â°C, at which time it was quenched with saturated ammonium chloride and extracted with ethyl acetate. The organic layer was separated, washed with water, and purified directly by flash chromatography (ethyl acetate to ethyl acetate/methanol (9:1) + 1% NEt<sub>3</sub>) to provide the alkene (15 mg, 0.027 mmol, 11% yield, mixture of alkene isomers by NMR) as a red oil.</div><div class="NLM_p last">A flask was charged with (<i>R</i>)-1-(2-(1<i>H</i>-1,2,4-triazol-1-yl)acetyl)-4-(4-fluorobenzylidene)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (15 mg, 0.027 mmol), Pd/C (10%, 50 mg), and methanol(5 mL). The mixture was stirred under a hydrogen atmosphere (balloon) for 2 h at room temperature, at which time it was concentrated and purified by flash chromatography (ethyl acetate to ethyl acetate/methanol (9:1) + 1% NEt<sub>3</sub>) to provide <b>36</b> (10 mg, 0.019 mmol, 69%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 8.61 (s, 1H), 8.22 (s, 1H), 7.98 (s, 1H), 7.45 (d, <i>J</i> = 9.0 Hz, 2H), 7.18â7.14 (m, 2H), 7.03â6.91 (m, 8H), 5.04 (d, <i>J</i> = 16.1 Hz, 1H), 4.95 (d, <i>J</i> = 16.1 Hz, 1H), 4.64â4.60 (m, 1H), 3.76 (dd, <i>J</i> = 10.1, 7.0 Hz, 1H), 3.30â3.20 (m, 1H), 2.85 (dd, <i>J</i> = 13.1, 6.6 Hz, 1H), 2.73 (dd, <i>J</i> = 13.6, 7.9 Hz, 1H), 2.63â2.53 (m, 1H), 2.32â2.28 (m, 2H). MS (EI) for C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>, found 518.2 (MH<sup>+</sup>).</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (2<i>R</i>,4<i>S</i>)-1-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)acetyl)-4-(4-fluorobenzyl)-<i>N</i>-(4-(4-fluorophenoxy)phenyl)pyrrolidine-2-carboxamide (ent-<b>37</b>)</h3><div class="NLM_p">A flask was charged with <b>56</b> (5.00 g, 38.8 mmol), <i>p</i>-toluenesulfonic acid monohydrate (369 mg, 1.94 mmol), and ethanol (100 mL). The mixture was stirred overnight at room temperature. The reaction mixture was concentrated in vacuo to provide (<i>R</i>)-ethyl 5-oxopyrrolidine-2-carboxylate (38.8 mmol, quant) which was carried forward without further purification.</div><div class="NLM_p last">Conversion of (<i>R</i>)-ethyl 5-oxopyrrolidine-2-carboxylate to ent-<b>37</b> was done in a similar manner as <b>37</b> except the ester hydrolysis was carried out using 2 N KOH/methanol (1:1) in place of trifluoroacetic acid. Upon purification by reverse phase HPLC, ent-<b>37</b> (115 mg, 23% yield) was provided as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 8.96 (s, 1H), 7.78 (d, <i>J</i> = 11.2 Hz, 2H), 7.43 (d, <i>J</i> = 9.2 Hz, 2H), 7.16 (dd, <i>J</i> = 8.6, 5.0 Hz, 2H), 7.04â6.98 (m, 4H), 6.94â6.89 (m, 4H), 5.28 (d, <i>J</i> = 16.0 Hz, 1H), 5.14 (d, <i>J</i> = 16.4 Hz, 1H), 4.80 (d, <i>J</i> = 7.6 Hz, 1H), 3.68 (dd, <i>J</i> = 9.2, 8.0 Hz, 1H), 3.27 (t, <i>J</i> = 9.6 Hz, 1H), 3.02â2.92 (m, 1H), 2.88 (dd, <i>J</i> = 13.8, 6.6 Hz, 1H), 2.68 (dd, <i>J</i> = 14.0, 8.2 Hz, 1H), 2.61â2.56 (m, 1H), 1.75â1.66 (m, 1H). MS (EI) for C<sub>28</sub>H<sub>25</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub>, found 518.2 (MH<sup>+</sup>).</div></div><div id="sec5_37_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> CNG cAMP Assay</h3><div class="NLM_p last">Frozen HEK293 cells expressing the CNG channel and S1P<sub>1</sub> (BD Biosciences, San Jose, CA) were thawed and plated into the wells of a black, clear-bottom, 384-well CellBind plate (Corning, Corning, NY) at 14â000 cells per well. HEK293 cells expressing the CNG channel and CB1 (BD Biosciences) were cultured and plated under the same conditions. The cells were incubated for 16 h at 37 Â°C in complete DMEM medium (Invitrogen Carlsbad, CA) containing 10% FBS (HyClone Logan, UT), 250 Î¼g/mL Geneticin (Invitrogen), and1 Î¼g/mL puromycin (Sigma-Aldrich, St. Louis, MO). A membrane potential dye (BD Biosciences) was added, and the plates were incubated for 2â2.5 h at room temperature. Test compounds were tested at maximum concentrations of 10 and 1 Î¼M for the agonist and antagonist assays, respectively. Compounds were diluted in DMSO (10 concentration points, 3-fold each) and added to the assay plate at a final DMSO concentration of 0.5%. For each compound, there were duplicate assay plates and each assay plate had duplicate wells per concentration point. Test compounds were added to the cells in a DPBS solution containing 25 Î¼M Ro 20-1724 (Sigma-Aldrich), 500 nM A2b receptor agonist NECA (Sigma-Aldrich), and 10 nM (EC<sub>95</sub>) Merck S1P<sub>1</sub> agonist (<b>26</b>) or S1P (Avanti Alabaster, AL) and incubated for 90 min. For CB1, the competing agonist was 10 nM CP-55940 (Sigma-Aldrich). The assay plate was read before compound addition (<i>T</i><sub>0</sub>) and after the 90 min incubation (<i>T</i><sub>90</sub>) using an EnVision plate reader (PerkinElmer, Waltham, MA) at an excitation wavelength of 350 nm and an emission wavelength of 590 nm. The <i>T</i><sub>90</sub>/<i>T</i><sub>0</sub> ratio was determined for each concentration of the test compounds. The percent antagonist activity was determined as [(test compound â agonist alone control)/(NECA alone control â agonist alone control)] Ã 100. The percent activities were plotted against compound concentration to determine IC<sub>50</sub> using XLFit (IDBS, Alameda, CA).</div></div><div id="sec5_37_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Luciferase Selectivity Assay</h3><div class="NLM_p last">For the Tango Î²-arrestin recruitment assay (luciferase selectivity assay), the cytoplasmic C-terminus of S1P<sub>1</sub> is tethered to the tTA transcriptional activator with a linker that contains a cleavage site for the N1a protease from tobacco etch virus (TEV protease). The C-terminus of the human Î²-arrestin 2 protein is fused to TEV protease. Binding of an agonist recruits the Î²-arrestin-TEV fusion protein to the receptor, resulting in cleavage of the linker and release of tTA to enter the nucleus and subsequently activate a tTA-dependent luciferase reporter gene. Frozen HEK293 cells transiently transected with receptor cDNAs for S1P<sub>1</sub>, S1P<sub>2</sub>, or S1P<sub>3</sub> (Invitrogen) were thawed and suspended in 10 mL of Pro293a-CDM culture medium (Invitrogen) supplemented with 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Invitrogen), 1Ã Pen/Strep (100 units/mL penicillin and 100 Î¼g/mL streptomycin, Invitrogen), and 0.1% fatty acid free BSA (Sigma-Aldrich). Cells were added to the wells of a 384-well white opaque bottom assay plate (PerkinElmer) at 3000â6000 cells per well, and the plate was incubated for approximately 4 h in a 37 Â°C incubator. Test compounds were tested at maximum concentrations of 1 Î¼M. Compounds were diluted in DMSO (10 concentration points, 3-fold each) and added to the assay plate at a 1% final DMSO concentration. For each compound, there were duplicate assay plates and each assay plate had duplicate wells per concentration point. The plate was incubated at 37 Â°C for 30 min. For S1P<sub>1</sub>, S1P<sub>2</sub>, and S1P<sub>3</sub> antagonist assays, the agonist S1P was added at a final EC<sub>95</sub> concentration of 400, 100, and 400 nM, respectively. Following agonist additions, the assay plates were incubated in a 37 Â°C incubator for 16â18 h. Luciferase assay reagent was added and luminescence measured in an EnVision plate reader (PerkinElmer). Percent antagonist activity was determined as [(positive control â test compound)/(positive control â background)] Ã 100, where background is the luminescence of the DMSO control and the positive control is the luminescence from cells incubated with 400 nM (EC<sub>95</sub>) S1P. The percent activities were plotted against compound concentration to determine IC<sub>50</sub> using XLFit (IDBS).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/jm201533b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Materials and methods used in determination of pharmacokinetic, efficacy, MLM oxidation, and CYP450 inhibition data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201533b/suppl_file/jm201533b_si_001.pdf">jm201533b_si_001.pdf (108.27 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201533b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry W. B. Johnson</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#375f5d585f5944585977524f525b5e4f5e441954585a"><span class="__cf_email__" data-cfemail="d6bebcb9beb8a5b9b896b3aeb3babfaebfa5f8b5b9bb">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed A. Ibrahim</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joon Won Jeong</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary L. Lewis</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xian Shi</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin T. Noguchi</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Williams</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Leahy</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Nuss</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Woolfrey</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Banica</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frauke Bentzien</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Chien Chou</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Gibson</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathan Heald</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Lamb</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry Mattheakis</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Matthews</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Shipway</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiang Wu</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">WenTao Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sihong Zhou</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geetha Shankar</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery, Exelixis, 169 Harbor Way, South San Francisco, California 94083, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d591e4636-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Siamak Dailami for analytical support; Lory Tan and John Bui for collecting the reported ADME data; Atulkumar Ramaiya, Ron Aoyama, Scott Womble, and Michael Yakes for obtaining PK data; Eliana Bustamante, Dorothy Trent, Melanie Dimapasoc, Yelena Zherebina, Shaun Nguyen, and Josh Rulloda in Compound Repository; Fawn Qian and Danny Tam from Molecular and Cellular Pharmacology; and Amy Lew for editorial comments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> Abbreviations Used</h2><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr><tr><td class="NLM_term">S1P<sub>1</sub></td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate receptor 1</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">CBz</td><td class="NLM_def"><p class="first last">benzyl carbamate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64704" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64704" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">â</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1991&pages=155-167&author=H.+Zhangauthor=N.+N.+Desaiauthor=A.+Oliveraauthor=T.+Sekiauthor=G.+Brookerauthor=S.+Spiegel&title=Sphingosine-1-phosphate%2C+a+novel+lipid%2C+involved+in+cellular+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDesai%26aufirst%3DN.%2BN.%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DBrooker%26aufirst%3DG.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%252C%2520a%2520novel%2520lipid%252C%2520involved%2520in%2520cellular%2520proliferation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1991%26volume%3D114%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirianov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleuser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanek, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coso, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutkind, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">381</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">â</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1038%2F381800a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=8657285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=800-803&author=O.+Cuvillierauthor=G.+Pirianovauthor=B.+Kleuserauthor=P.+G.+Vanekauthor=O.+A.+Cosoauthor=J.+S.+Gutkindauthor=S.+Spiegel&title=Suppression+of+ceramide-mediated+programmed+cell+death+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span></div><div class="casAuthors">Cuvillier, Olivier; Pirianov, Grisha; Kleuser, Burkhard; Vanek, Philip G.; Coso, Omar A.; Gutkind, J. Silvio; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6585</span>),
    <span class="NLM_cas:pages">800-803</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Ceramide is an important regulatory participant of programmed cell death (apoptosis) induced by tumor-necrosis factor (TMF)-Î± and Fas ligand, members of the TNF superfamily.  Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum.  Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphol. changes, which result from increased concns. of ceramide.  Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-1-phosphate.  Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway, it counteracts the ceramide-induced activation of stress-activated protein kinase of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases dets. the fate of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xEuzICMjarVg90H21EOLACvtfcHk0ljzCcR3ZuSg2g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D&md5=50d91e59dc03600594fd0a236ecc2838</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F381800a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381800a0%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DPirianov%26aufirst%3DG.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DVanek%26aufirst%3DP.%2BG.%26aulast%3DCoso%26aufirst%3DO.%2BA.%26aulast%3DGutkind%26aufirst%3DJ.%2BS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520ceramide-mediated%2520programmed%2520cell%2520death%2520by%2520sphingosine-1-phosphate%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D800%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brocklyn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Movafagh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukowska-Grojec, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate stimulates cell migration through a G<sub>i</sub>-coupled cell surface receptor: potential involvement in angiogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">35343</span><span class="NLM_x">â</span> <span class="NLM_lpage">35350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=35343-35350&author=F.+Wangauthor=J.+R.+Van+Brocklynauthor=J.+P.+Hobsonauthor=S.+Movafaghauthor=Z.+Zukowska-Grojecauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+1-phosphate+stimulates+cell+migration+through+a+Gi-coupled+cell+surface+receptor%3A+potential+involvement+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DHobson%26aufirst%3DJ.%2BP.%26aulast%3DMovafagh%26aufirst%3DS.%26aulast%3DZukowska-Grojec%26aufirst%3DZ.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520stimulates%2520cell%2520migration%2520through%2520a%2520Gi-coupled%2520cell%2520surface%2520receptor%253A%2520potential%2520involvement%2520in%2520angiogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D35343%26epage%3D35350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lee, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ancellin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaâafi, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">â</span> <span class="NLM_lpage">312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=301-312&author=M.-J.+Leeauthor=S.+Thangadaauthor=K.+P.+Claffeyauthor=N.+Ancellinauthor=C.+H.+Liuauthor=M.+Klukauthor=M.+Volpiauthor=R.+I.+Sha%E2%80%99afiauthor=T.+Hla&title=Vascular+endothelial+cell+adherens+junction+assembly+and+morphogenesis+induced+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-J.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DClaffey%26aufirst%3DK.%2BP.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DKluk%26aufirst%3DM.%26aulast%3DVolpi%26aufirst%3DM.%26aulast%3DSha%25E2%2580%2599afi%26aufirst%3DR.%2BI.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DVascular%2520endothelial%2520cell%2520adherens%2520junction%2520assembly%2520and%2520morphogenesis%2520induced%2520by%2520sphingosine-1-phosphate%26jtitle%3DCell%26date%3D1999%26volume%3D99%26spage%3D301%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Graeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">4084</span><span class="NLM_x">â</span> <span class="NLM_lpage">4087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=4084-4087&author=M.+Graelerauthor=G.+Shankarauthor=E.+J.+Goetzl&title=Cutting+edge%3A+suppression+of+T+cell+chemotaxis+by+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraeler%26aufirst%3DM.%26aulast%3DShankar%26aufirst%3DG.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DCutting%2520edge%253A%2520suppression%2520of%2520T%2520cell%2520chemotaxis%2520by%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D4084%26epage%3D4087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lee, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brocklyn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzeleev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">1552</span><span class="NLM_x">â</span> <span class="NLM_lpage">1555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1552-1555&author=M.-J.+Leeauthor=J.+R.+Van+Brocklynauthor=S.+Thangadaauthor=C.+H.+Liuauthor=A.+R.+Handauthor=R.+Menzeleevauthor=S.+Spiegelauthor=T.+Hla&title=Sphingosine-1-phosphate+as+a+ligand+for+the+G+protein-coupled+receptor+EDG-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-J.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DHand%26aufirst%3DA.%2BR.%26aulast%3DMenzeleev%26aufirst%3DR.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DSphingosine-1-phosphate%2520as%2520a%2520ligand%2520for%2520the%2520G%2520protein-coupled%2520receptor%2520EDG-1%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1552%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, T.</span><span> </span><span class="NLM_article-title">An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">â</span> <span class="NLM_lpage">9313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=9308-9313&author=T.+Hlaauthor=T.+Maciag&title=An+abundant+transcript+induced+in+differentiating+human+endothelial+cells+encodes+a+polypeptide+with+structural+similarities+to+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DMaciag%26aufirst%3DT.%26atitle%3DAn%2520abundant%2520transcript%2520induced%2520in%2520differentiating%2520human%2520endothelial%2520cells%2520encodes%2520a%2520polypeptide%2520with%2520structural%2520similarities%2520to%2520G-protein-coupled%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D9308%26epage%3D9313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeldt, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">â</span> <span class="NLM_lpage">961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=951-961&author=Y.+Liuauthor=R.+Wadaauthor=T.+Yamashitaauthor=Y.+Miauthor=C.+X.+Dengauthor=J.+P.+Hobsonauthor=H.+M.+Rosenfeldtauthor=V.+E.+Navaauthor=S.+S.+Chaeauthor=M.+J.+Leeauthor=C.+H.+Liuauthor=T.+Hlaauthor=S.+Spiegelauthor=R.+L.+Proia&title=Edg-1%2C+the+G+protein-coupled+receptor+for+sphingosine-1-phosphate%2C+is+essential+for+vascular+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWada%26aufirst%3DR.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DC.%2BX.%26aulast%3DHobson%26aufirst%3DJ.%2BP.%26aulast%3DRosenfeldt%26aufirst%3DH.%2BM.%26aulast%3DNava%26aufirst%3DV.%2BE.%26aulast%3DChae%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DEdg-1%252C%2520the%2520G%2520protein-coupled%2520receptor%2520for%2520sphingosine-1-phosphate%252C%2520is%2520essential%2520for%2520vascular%2520maturation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D951%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">â</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lipDF_vzbs9AQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+modulators+of+sphingosine-1-phosphate+receptors+as+barrier-oriented+therapeutic+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptors%2520as%2520barrier-oriented%2520therapeutic%2520molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">â</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+J.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+progress+in+the+development+of+selective+S1P1+receptor+agonists+for+the+treatment+of+inflammatory+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lipDF_vzbs9AQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selective%2520S1P1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yonesu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span> </span><span class="NLM_article-title">A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1500</span><span class="NLM_x">â</span> <span class="NLM_lpage">1505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1248%2Fbpb.33.1500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=20823564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKlu7bO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=1500-1505&author=K.+Yonesuauthor=T.+Nakamuraauthor=Y.+Mizunoauthor=C.+Suzukiauthor=T.+Nagayamaauthor=S.+Satohauthor=F.+Nara&title=A+novel+sphingosine-1-phosphate+receptor+1+antagonist+prevents+the+proliferation+and+relaxation+of+vascular+endothelial+cells+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate</span></div><div class="casAuthors">Yonesu, Kiyoaki; Nakamura, Tsuyoshi; Mizuno, Yumiko; Suzuki, Chie; Nagayama, Takahiro; Satoh, Susumu; Nara, Futoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1500-1505</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A sphingosine-1-phosphate receptor 1 (S1P1) antagonist is expected to be an anti-angiogenic compd.; however, there are few reports that demonstrated that a S1P1 inhibitor improved the disease state in an angiogenic animal model.  Since we detd. that a prototype S1P1 antagonist was an in vivo angiogenesis inhibitor, we developed the derivs. to acquire more effective compds.  In this report, we show the S1P1 antagonistic activity of some representatives, esp. compd. 5 {sodium 4-[(4-butoxyphenyl)thio]-2'-[{4-[(heptylthio)methyl]-2-hydroxyphenyl}(hydroxy)methyl]biphenyl-3-sulfonate}.  The IC50 values calcd. from an intracellular cAMP measurement assay and a [33P]sphingosine-1-phosphate (Sph-1-P)/S1P1 binding assay were 38 and 200 nM, resp.  A subtype specificity test for the other Sph-1-P receptors showed that compd. 5 was the S1P1-directional antagonist.  It also inhibited the proliferation, migration, and tube formation of human umbilical vein endothelial cells stimulated by Sph-1-P with the IC50 values of 18, 650, and 230 nM, resp.  A cytotoxicity assay concurrently performed with a tube formation assay supported the hypothesis that these biol. effects were not due to its cytotoxicity.  Furthermore, administration (10 mg/kg, i.v.) to anesthetized Sprague-Dawley rats inhibited Sph-1-P-induced hypotension by 100-90% for 30 min.  This is presumably through the inhibition of Sph-1-P-induced vasorelaxation, mainly by the blocking of S1P1 and/or S1P3.  Taken together, these results show that compd. 5 is an inhibitor of in vitro and in vivo Sph-1-P signaling, and that it will be useful to elucidate the in vivo effect of Sph-1-P on vascular endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5mMWxMxOoMLVg90H21EOLACvtfcHk0lipDF_vzbs9AQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKlu7bO&md5=64b11266689f0a99f1bbd2f498ab7e2c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1248%2Fbpb.33.1500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.33.1500%26sid%3Dliteratum%253Aachs%26aulast%3DYonesu%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DC.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DNara%26aufirst%3DF.%26atitle%3DA%2520novel%2520sphingosine-1-phosphate%2520receptor%25201%2520antagonist%2520prevents%2520the%2520proliferation%2520and%2520relaxation%2520of%2520vascular%2520endothelial%2520cells%2520by%2520sphingosine-1-phosphate%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D33%26spage%3D1500%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonesu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of a novel class of S1P<sub>1</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3548</span><span class="NLM_x">â</span> <span class="NLM_lpage">3564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=3548-3564&author=T.+Nakamuraauthor=K.+Yonesuauthor=Y.+Mizunoauthor=C.+Suzukiauthor=Y.+Sakataauthor=Y.+Takuwaauthor=F.+Naraauthor=S.+Satoh&title=Synthesis+and+SAR+studies+of+a+novel+class+of+S1P1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DYonesu%26aufirst%3DK.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DC.%26aulast%3DSakata%26aufirst%3DY.%26aulast%3DTakuwa%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DSatoh%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520a%2520novel%2520class%2520of%2520S1P1%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D3548%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P<sub>1</sub> antagonist in vivo</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">â</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1038%2Fnchembio804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=16829954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFyqsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=434-441&author=M.+G.+Sannaauthor=S.+K.+Wangauthor=P.+J.+Gonzalez-Cabreraauthor=A.+Donauthor=D.+Marsolaisauthor=M.+P.+Matheuauthor=S.+H.+Weiauthor=I.+Parkerauthor=E.+Joauthor=W.+Chengauthor=M.+D.+Cahalanauthor=C.-H.+Wongauthor=H.+Rosen&title=Enhancement+of+capillary+leakage+and+restoration+of+lymphocyte+egress+by+a+chiral+S1P1+antagonist+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo</span></div><div class="casAuthors">Sanna, M. Germana; Wang, Sheng-Kai; Gonzalez-Cabrera, Pedro J.; Don, Anthony; Marsolais, David; Matheu, Melanie P.; Wei, Sindy H.; Parker, Ian; Jo, Euijung; Cheng, Wei-Chieh; Cahalan, Michael D.; Wong, Chi-Huey; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">434-441</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P, 1) regulates vascular barrier and lymphoid development, as well as lymphocyte egress from lymphoid organs, by activating high-affinity S1P1 receptors.  The authors used reversible chem. probes (i) to gain mechanistic insights into S1P systems organization not accessible through genetic manipulations and (ii) to investigate their potential for therapeutic modulation.  Vascular (but not airway) administration of the preferred R enantiomer of an in vivo-active chiral S1P11 receptor antagonist induced loss of capillary integrity in mouse skin and lung.  In contrast, the antagonist did not affect the no. of constitutive blood lymphocytes.  Instead, alteration of lymphocyte trafficking and phenotype required supraphysiol. elevation of S1P1 tone and was reversed by the antagonist.  In vivo two-photon imaging of lymph nodes confirmed requirements for obligate agonism, and the data were consistent with the presence of a stromal barrier mechanism for gating lymphocyte egress.  Thus, chem. modulation reveals differences in S1P-S1P1 'set points' among tissues and highlights both mechanistic advantages (lymphocyte sequestration) and risks (pulmonary edema) of therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3H_AoUm7AkrVg90H21EOLACvtfcHk0lgYnVjfgH6URg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFyqsrw%253D&md5=c7cf6472393abe2d43851c5cd329e968</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnchembio804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio804%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.%2BK.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DDon%26aufirst%3DA.%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DEnhancement%2520of%2520capillary%2520leakage%2520and%2520restoration%2520of%2520lymphocyte%2520egress%2520by%2520a%2520chiral%2520S1P1%2520antagonist%2520in%2520vivo%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D434%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Inoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span> </span><span class="NLM_article-title">Negative regulation of endothelial morphogenesis and angiogenesis by S1P<sub>2</sub> receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">â</span> <span class="NLM_lpage">300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2006&pages=293-300&author=I.+Inokiauthor=N.+Takuwaauthor=N.+Sugimotoauthor=K.+Yoshiokaauthor=S.+Takataauthor=S.+Kanekoauthor=Y.+Takuwa&title=Negative+regulation+of+endothelial+morphogenesis+and+angiogenesis+by+S1P2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoki%26aufirst%3DI.%26aulast%3DTakuwa%26aufirst%3DN.%26aulast%3DSugimoto%26aufirst%3DN.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DTakata%26aufirst%3DS.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DTakuwa%26aufirst%3DY.%26atitle%3DNegative%2520regulation%2520of%2520endothelial%2520morphogenesis%2520and%2520angiogenesis%2520by%2520S1P2%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D346%26spage%3D293%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euijung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anh, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">â</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=J.+Euijungauthor=C.+Alfonsoauthor=M.-Y.+Anhauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DEuijung%26aufirst%3DJ.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAnh%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span> </span><span class="NLM_article-title">ZD6474âa novel inhibitor of VEGFR and EGFR tyrosine kinase activity</span> <span class="citation_source-journal">Br. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">S6</span><span class="NLM_x">â</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=S6-S13&author=A.+J.+Ryanauthor=S.+R.+Wedge&title=ZD6474%E2%80%94a+novel+inhibitor+of+VEGFR+and+EGFR+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DZD6474%25E2%2580%2594a%2520novel%2520inhibitor%2520of%2520VEGFR%2520and%2520EGFR%2520tyrosine%2520kinase%2520activity%26jtitle%3DBr.%2520J.%2520Cancer.%26date%3D2005%26volume%3D92%26spage%3DS6%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">â</span> <span class="NLM_lpage">6665</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benzyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benzyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">â</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=Y.-H.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area â¤140 Ã2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljLNXSS6B1VYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DY.-H.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ibrahim, M. A.; Jeong, J. W.; Johnson, H. W. B.; Kearney, P.; Leahy, J. W.; Lewis, G. L.; Noguchi, R. T.; Nuss, J. M.</span><span> </span><span class="NLM_article-title">Sphingosine-1-Phosphate Receptor Antagonists</span>. PCT Int. Appl. WO201045580A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+A.+Ibrahim&author=J.+W.+Jeong&author=H.+W.+B.+Johnson&author=P.+Kearney&author=J.+W.+Leahy&author=G.+L.+Lewis&author=R.+T.+Noguchi&author=J.+M.+Nuss&title=Sphingosine-1-Phosphate+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DM.%2BA.%26atitle%3DSphingosine-1-Phosphate%2520Receptor%2520Antagonists%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, M.</span><span> </span><span class="NLM_article-title">Amino acid synthesis using (<span class="smallcaps smallerCapital">l</span>)-pyroglutamic acid as a chiral starting material</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">7459</span><span class="NLM_x">â</span> <span class="NLM_lpage">7468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=7459-7468&author=J.+E.+Baldwinauthor=T.+Mirandaauthor=M.+Maloney&title=Amino+acid+synthesis+using+%28l%29-pyroglutamic+acid+as+a+chiral+starting+material"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DMiranda%26aufirst%3DT.%26aulast%3DMaloney%26aufirst%3DM.%26atitle%3DAmino%2520acid%2520synthesis%2520using%2520%2528l%2529-pyroglutamic%2520acid%2520as%2520a%2520chiral%2520starting%2520material%26jtitle%3DTetrahedron%26date%3D1989%26volume%3D45%26spage%3D7459%26epage%3D7468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambal, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A. N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.-C.</span><span> </span><span class="NLM_article-title">Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7333</span><span class="NLM_x">â</span> <span class="NLM_lpage">7342</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0500830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7333-7342&author=C.+R.+Ganellinauthor=P.+B.+Bishopauthor=R.+B.+Bambalauthor=S.+M.+T.+Chanauthor=B.+Leblondauthor=A.+N.+J.+Mooreauthor=L.+Zhaoauthor=P.+Bourgeatauthor=C.+Roseauthor=F.+Vargasauthor=J.-C.+Schwartz&title=Inhibitors+of+tripeptidyl+peptidase+II.+3.+Derivation+of+butabindide+by+successive+structure+optimizations+leading+to+a+potential+general+approach+to+designing+exopeptidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0500830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500830%26sid%3Dliteratum%253Aachs%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DBishop%26aufirst%3DP.%2BB.%26aulast%3DBambal%26aufirst%3DR.%2BB.%26aulast%3DChan%26aufirst%3DS.%2BM.%2BT.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DMoore%26aufirst%3DA.%2BN.%2BJ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DRose%26aufirst%3DC.%26aulast%3DVargas%26aufirst%3DF.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DInhibitors%2520of%2520tripeptidyl%2520peptidase%2520II.%25203.%2520Derivation%2520of%2520butabindide%2520by%2520successive%2520structure%2520optimizations%2520leading%2520to%2520a%2520potential%2520general%2520approach%2520to%2520designing%2520exopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7333%26epage%3D7342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Suresh Narva, Xuqiong Xiong, Xudong Ma, Yoshimasa Tanaka, Yanling Wu, <span class="NLM_string-name hlFld-ContribAuthor">Wen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Biphenyl-1,2,3-Triazol-Benzonitrile Derivatives as PD-1/PD-L1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (33)
                                     , 21181-21190. <a href="https://doi.org/10.1021/acsomega.0c02916" title="DOI URL">https://doi.org/10.1021/acsomega.0c02916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c02916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c02916%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BBiphenyl-1%25252C2%25252C3-Triazol-Benzonitrile%252BDerivatives%252Bas%252BPD-1%25252FPD-L1%252BInhibitors%26aulast%3DNarva%26aufirst%3DSuresh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17062020%26date%3D28072020%26date%3D14082020%26volume%3D5%26issue%3D33%26spage%3D21181%26epage%3D21190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">C. Weck, E. Nauha, <span class="NLM_string-name hlFld-ContribAuthor">T. Gruber</span>. </span><span class="cited-content_cbyCitation_article-title">Does the Exception Prove the Rule? A Comparative Study of Supramolecular Synthons in a Series of Lactam Esters. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2019,</strong> <em>19 </em>
                                    (5)
                                     , 2899-2911. <a href="https://doi.org/10.1021/acs.cgd.9b00116" title="DOI URL">https://doi.org/10.1021/acs.cgd.9b00116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.9b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.9b00116%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DDoes%252Bthe%252BException%252BProve%252Bthe%252BRule%25253F%252BA%252BComparative%252BStudy%252Bof%252BSupramolecular%252BSynthons%252Bin%252Ba%252BSeries%252Bof%252BLactam%252BEsters%26aulast%3DWeck%26aufirst%3DC.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24012019%26date%3D22032019%26date%3D29032019%26date%3D26032019%26volume%3D19%26issue%3D5%26spage%3D2899%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward J.  Hennessy</span>, <span class="hlFld-ContribAuthor ">Vibha  Oza</span>, <span class="hlFld-ContribAuthor ">Ammar  Adam</span>, <span class="hlFld-ContribAuthor ">Kate  Byth</span>, <span class="hlFld-ContribAuthor ">Lillian  Castriotta</span>, <span class="hlFld-ContribAuthor ">Gurmit  Grewal</span>, <span class="hlFld-ContribAuthor ">Geraldine A.  Hamilton</span>, <span class="hlFld-ContribAuthor ">Victor M.  Kamhi</span>, <span class="hlFld-ContribAuthor ">Paula  Lewis</span>, <span class="hlFld-ContribAuthor ">Danyang  Li</span>, <span class="hlFld-ContribAuthor ">Paul  Lyne</span>, <span class="hlFld-ContribAuthor ">Linda  Ãster</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rooney</span>, <span class="hlFld-ContribAuthor ">Jamal C.  Saeh</span>, <span class="hlFld-ContribAuthor ">Li  Sha</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Shengua  Wen</span>, <span class="hlFld-ContribAuthor ">Yafeng  Xue</span>, and <span class="hlFld-ContribAuthor ">Bin  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 7057-7075. <a href="https://doi.org/10.1021/acs.jmedchem.5b01078" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01078%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BOptimization%252Bof%252BBenzimidazole%252BSulfonamides%252Bas%252BOrally%252BBioavailable%252BSphingosine%252B1-Phosphate%252BReceptor%252B1%252BAntagonists%252Bwith%252Bin%252BVivo%252BActivity%26aulast%3DHennessy%26aufirst%3DEdward%2BJ.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10072015%26date%3D26082015%26date%3D10092015%26date%3D20082015%26volume%3D58%26issue%3D17%26spage%3D7057%26epage%3D7075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona I.  McGonagle</span>, <span class="hlFld-ContribAuthor ">Helen F.  Sneddon</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Molar Efficiency: A Useful Metric To Gauge Relative Reaction Efficiency in Discovery Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2014,</strong> <em>2 </em>
                                    (3)
                                     , 523-532. <a href="https://doi.org/10.1021/sc4004532" title="DOI URL">https://doi.org/10.1021/sc4004532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/sc4004532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fsc4004532%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DMolar%252BEfficiency%25253A%252BA%252BUseful%252BMetric%252BTo%252BGauge%252BRelative%252BReaction%252BEfficiency%252Bin%252BDiscovery%252BMedicinal%252BChemistry%26aulast%3DMcGonagle%26aufirst%3DFiona%2BI.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06112013%26date%3D28112013%26date%3D06122013%26date%3D03032014%26date%3D02122013%26volume%3D2%26issue%3D3%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig S.  Takeuchi</span>, <span class="hlFld-ContribAuthor ">Byung Gyu  Kim</span>, <span class="hlFld-ContribAuthor ">Charles M.  Blazey</span>, <span class="hlFld-ContribAuthor ">Sunghoon  Ma</span>, <span class="hlFld-ContribAuthor ">Henry W. B.  Johnson</span>, <span class="hlFld-ContribAuthor ">Neel K.  Anand</span>, <span class="hlFld-ContribAuthor ">Arlyn  Arcalas</span>, <span class="hlFld-ContribAuthor ">Tae Gon  Baik</span>, <span class="hlFld-ContribAuthor ">Chris A.  Buhr</span>, <span class="hlFld-ContribAuthor ">Jonah  Cannoy</span>, <span class="hlFld-ContribAuthor ">Sergey  Epshteyn</span>, <span class="hlFld-ContribAuthor ">Anagha  Joshi</span>, <span class="hlFld-ContribAuthor ">Katherine  Lara</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Lee</span>, <span class="hlFld-ContribAuthor ">Longcheng  Wang</span>, <span class="hlFld-ContribAuthor ">James W.  Leahy</span>, <span class="hlFld-ContribAuthor ">John M.  Nuss</span>, <span class="hlFld-ContribAuthor ">Naing  Aay</span>, <span class="hlFld-ContribAuthor ">Ron  Aoyama</span>, <span class="hlFld-ContribAuthor ">Paul  Foster</span>, <span class="hlFld-ContribAuthor ">Jae  Lee</span>, <span class="hlFld-ContribAuthor ">Isabelle  Lehoux</span>, <span class="hlFld-ContribAuthor ">Narsimha  Munagala</span>, <span class="hlFld-ContribAuthor ">Arthur  Plonowski</span>, <span class="hlFld-ContribAuthor ">Sharmila  Rajan</span>, <span class="hlFld-ContribAuthor ">John  Woolfrey</span>, <span class="hlFld-ContribAuthor ">Kyoko  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Peter  Lamb</span>, and <span class="hlFld-ContribAuthor ">Nicole  Miller</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Class of Highly Potent, Selective, ATP-Competitive, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2218-2234. <a href="https://doi.org/10.1021/jm3007933" title="DOI URL">https://doi.org/10.1021/jm3007933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3007933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3007933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BClass%252Bof%252BHighly%252BPotent%25252C%252BSelective%25252C%252BATP-Competitive%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%26aulast%3DTakeuchi%26aufirst%3DCraig%2BS.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D06062012%26date%3D07032013%26date%3D28032013%26date%3D08022013%26volume%3D56%26issue%3D6%26spage%3D2218%26epage%3D2234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Angst</span>, <span class="hlFld-ContribAuthor ">Philipp  Janser</span>, <span class="hlFld-ContribAuthor ">Jean  Quancard</span>, <span class="hlFld-ContribAuthor ">Peter  Buehlmayer</span>, <span class="hlFld-ContribAuthor ">Frederic  Berst</span>, <span class="hlFld-ContribAuthor ">Lukas  Oberer</span>, <span class="hlFld-ContribAuthor ">Christian  Beerli</span>, <span class="hlFld-ContribAuthor ">Markus  Streiff</span>, <span class="hlFld-ContribAuthor ">Charles  Pally</span>, <span class="hlFld-ContribAuthor ">Rene  Hersperger</span>, <span class="hlFld-ContribAuthor ">Christian  Bruns</span>, <span class="hlFld-ContribAuthor ">Frederic  Bassilana</span>, and <span class="hlFld-ContribAuthor ">Birgit  Bollbuck</span>  . </span><span class="cited-content_cbyCitation_article-title">An Oral Sphingosine 1-Phosphate Receptor 1 (S1P1) Antagonist Prodrug with Efficacy in Vivo: Discovery, Synthesis, and Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9722-9734. <a href="https://doi.org/10.1021/jm3009508" title="DOI URL">https://doi.org/10.1021/jm3009508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3009508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3009508%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252BOral%252BSphingosine%252B1-Phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAntagonist%252BProdrug%252Bwith%252BEfficacy%252Bin%252BVivo%25253A%252BDiscovery%25252C%252BSynthesis%25252C%252Band%252BEvaluation%26aulast%3DAngst%26aufirst%3DDaniela%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D04072012%26date%3D26102012%26date%3D26112012%26date%3D15102012%26volume%3D55%26issue%3D22%26spage%3D9722%26epage%3D9734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James W.  Leahy</span>, <span class="hlFld-ContribAuthor ">Chris A.  Buhr</span>, <span class="hlFld-ContribAuthor ">Henry W. B.  Johnson</span>, <span class="hlFld-ContribAuthor ">Byung Gyu  Kim</span>, <span class="hlFld-ContribAuthor ">TaeGon  Baik</span>, <span class="hlFld-ContribAuthor ">Jonah  Cannoy</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Forsyth</span>, <span class="hlFld-ContribAuthor ">Joon Won  Jeong</span>, <span class="hlFld-ContribAuthor ">Matthew S.  Lee</span>, <span class="hlFld-ContribAuthor ">Sunghoon  Ma</span>, <span class="hlFld-ContribAuthor ">Kevin  Noson</span>, <span class="hlFld-ContribAuthor ">Longcheng  Wang</span>, <span class="hlFld-ContribAuthor ">Matthew  Williams</span>, <span class="hlFld-ContribAuthor ">John M.  Nuss</span>, <span class="hlFld-ContribAuthor ">Eric  Brooks</span>, <span class="hlFld-ContribAuthor ">Paul  Foster</span>, <span class="hlFld-ContribAuthor ">Leanne  Goon</span>, <span class="hlFld-ContribAuthor ">Nathan  Heald</span>, <span class="hlFld-ContribAuthor ">Charles  Holst</span>, <span class="hlFld-ContribAuthor ">Christopher  Jaeger</span>, <span class="hlFld-ContribAuthor ">Scott  Lam</span>, <span class="hlFld-ContribAuthor ">Julie  Lougheed</span>, <span class="hlFld-ContribAuthor ">Lam  Nguyen</span>, <span class="hlFld-ContribAuthor ">Arthur  Plonowski</span>, <span class="hlFld-ContribAuthor ">Joanne  Song</span>, <span class="hlFld-ContribAuthor ">Thomas  Stout</span>, <span class="hlFld-ContribAuthor ">Xiang  Wu</span>, <span class="hlFld-ContribAuthor ">Michael F.  Yakes</span>, <span class="hlFld-ContribAuthor ">Peiwen  Yu</span>, <span class="hlFld-ContribAuthor ">Wentao  Zhang</span>, <span class="hlFld-ContribAuthor ">Peter  Lamb</span>, and <span class="hlFld-ContribAuthor ">Olivia  Raeber</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase Î³ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (11)
                                     , 5467-5482. <a href="https://doi.org/10.1021/jm300403a" title="DOI URL">https://doi.org/10.1021/jm300403a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300403a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300403a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BPotent%252Band%252BOrally%252BBioavailable%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B3%252BInhibitors%26aulast%3DLeahy%26aufirst%3DJames%2BW.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22032012%26date%3D17052012%26date%3D14062012%26date%3D01052012%26volume%3D55%26issue%3D11%26spage%3D5467%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Lin</span>, <span class="hlFld-ContribAuthor ">Chunxian  Liang</span>, <span class="hlFld-ContribAuthor ">Lianjia  Zou</span>, <span class="hlFld-ContribAuthor ">Yanchun  Yin</span>, <span class="hlFld-ContribAuthor ">Jianyi  Wang</span>, <span class="hlFld-ContribAuthor ">Dandan  Chen</span>, <span class="hlFld-ContribAuthor ">Weisen  Lan</span>. </span><span class="cited-content_cbyCitation_article-title">Advance of structural modification of nucleosides scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113233. <a href="https://doi.org/10.1016/j.ejmech.2021.113233" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113233%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvance%252Bof%252Bstructural%252Bmodification%252Bof%252Bnucleosides%252Bscaffold%26aulast%3DLin%26aufirst%3DXia%26date%3D2021%26volume%3D214%26spage%3D113233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandrashekhar  Madasu</span>, <span class="hlFld-ContribAuthor ">Shailaja  Karri</span>, <span class="hlFld-ContribAuthor ">Rajendra  Sangaraju</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Sistla</span>, <span class="hlFld-ContribAuthor ">Mallavadhani Venkata  Uppuluri</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 111974. <a href="https://doi.org/10.1016/j.ejmech.2019.111974" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111974%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bnovel%252B1%25252C2%25252C3-triazole%252Bhybrids%252Bof%252Bmyrrhanone%252BB%252Bisolated%252Bfrom%252BCommiphora%252Bmukul%252Bgum%252Bresin%25253A%252BIdentification%252Bof%252Bpotent%252Bantiproliferative%252Bleads%252Bactive%252Bagainst%252Bprostate%252Bcancer%252Bcells%252B%252528PC-3%252529%26aulast%3DMadasu%26aufirst%3DChandrashekhar%26date%3D2020%26volume%3D188%26spage%3D111974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony S.  Fischl</span>, <span class="hlFld-ContribAuthor ">Xiaoen  Wang</span>, <span class="hlFld-ContribAuthor ">Beverly L.  Falcon</span>, <span class="hlFld-ContribAuthor ">Rowena  Almonte-Baldonado</span>, <span class="hlFld-ContribAuthor ">Diane  Bodenmiller</span>, <span class="hlFld-ContribAuthor ">Glenn  Evans</span>, <span class="hlFld-ContribAuthor ">Julie  Stewart</span>, <span class="hlFld-ContribAuthor ">Takako  Wilson</span>, <span class="hlFld-ContribAuthor ">Philip  Hipskind</span>, <span class="hlFld-ContribAuthor ">Jason  Manro</span>, <span class="hlFld-ContribAuthor ">Mark T.  Uhlik</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Chintharlapalli</span>, <span class="hlFld-ContribAuthor ">Damien  Gerald</span>, <span class="hlFld-ContribAuthor ">David C.  Alsop</span>, <span class="hlFld-ContribAuthor ">Laura E.  Benjamin</span>, <span class="hlFld-ContribAuthor ">Rupal S.  Bhatt</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (4)
                                     , 856-867. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0548" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0548</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0548%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DInhibition%252Bof%252BSphingosine%252BPhosphate%252BReceptor%252B1%252BSignaling%252BEnhances%252Bthe%252BEfficacy%252Bof%252BVEGF%252BReceptor%252BInhibition%26aulast%3DFischl%26aufirst%3DAnthony%2BS.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D4%26spage%3D856%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Sun</span>, <span class="hlFld-ContribAuthor ">Peng-Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosyl-tRNA synthetase inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (5)
                                     , 557-564. <a href="https://doi.org/10.1080/13543776.2017.1273350" title="DOI URL">https://doi.org/10.1080/13543776.2017.1273350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1273350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1273350%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTyrosyl-tRNA%252Bsynthetase%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DSun%26aufirst%3DJuan%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D557%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhu-Ping  Xiao</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Kang  Shi</span>, <span class="hlFld-ContribAuthor ">Na  Zhu</span>, <span class="hlFld-ContribAuthor ">Me-Qun  Xie</span>, <span class="hlFld-ContribAuthor ">Yu-Wen  Sun</span>, <span class="hlFld-ContribAuthor ">Ling-Xia  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Xiang  Xie</span>, <span class="hlFld-ContribAuthor ">Liang-Song  Zhu</span>, <span class="hlFld-ContribAuthor ">Nian  Tang</span>, <span class="hlFld-ContribAuthor ">Hui  Ouyang</span>, <span class="hlFld-ContribAuthor ">Xian-Hui  Li</span>, <span class="hlFld-ContribAuthor ">Guang-Cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 631-638. <a href="https://doi.org/10.1016/j.ejmech.2015.08.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Btyrosyl-tRNA%252Bsynthetase%252Binhibitors%252Bas%252Bantibacterial%252Bagents%252Bbased%252Bon%252Ba%252BN2-%252528arylacetyl%252529glycinanilide%252Bscaffold%26aulast%3DXiao%26aufirst%3DZhu-Ping%26date%3D2015%26volume%3D102%26spage%3D631%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward J.  Hennessy</span>, <span class="hlFld-ContribAuthor ">Gurmit  Grewal</span>, <span class="hlFld-ContribAuthor ">Kate  Byth</span>, <span class="hlFld-ContribAuthor ">Victor M.  Kamhi</span>, <span class="hlFld-ContribAuthor ">Danyang  Li</span>, <span class="hlFld-ContribAuthor ">Paul  Lyne</span>, <span class="hlFld-ContribAuthor ">Vibha  Oza</span>, <span class="hlFld-ContribAuthor ">Lucienne  Ronco</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rooney</span>, <span class="hlFld-ContribAuthor ">Jamal C.  Saeh</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (10)
                                     , 2041-2045. <a href="https://doi.org/10.1016/j.bmcl.2015.03.095" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.095%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bheterocyclic%252Bsulfonamides%252Bas%252Bsphingosine%252B1-phosphate%252Breceptor%252B1%252B%252528S1P1%252529%252Bantagonists%26aulast%3DHennessy%26aufirst%3DEdward%2BJ.%26date%3D2015%26volume%3D25%26issue%3D10%26spage%3D2041%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Mei  Xu</span>, <span class="hlFld-ContribAuthor ">En  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Yan-Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Jiao</span>, <span class="hlFld-ContribAuthor ">Ya-Zhuo  Guo</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and preliminary biological evaluation of 1,2,3-triazole-Jaspine B hybrids as potential cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>80 </em>, 593-604. <a href="https://doi.org/10.1016/j.ejmech.2014.03.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpreliminary%252Bbiological%252Bevaluation%252Bof%252B1%25252C2%25252C3-triazole-Jaspine%252BB%252Bhybrids%252Bas%252Bpotential%252Bcytotoxic%252Bagents%26aulast%3DXu%26aufirst%3DJin-Mei%26date%3D2014%26volume%3D80%26spage%3D593%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Bigaud</span>, <span class="hlFld-ContribAuthor ">Danilo  Guerini</span>, <span class="hlFld-ContribAuthor ">Andreas  Billich</span>, <span class="hlFld-ContribAuthor ">Frederic  Bassilana</span>, <span class="hlFld-ContribAuthor ">Volker  Brinkmann</span>. </span><span class="cited-content_cbyCitation_article-title">Second generation S1P pathway modulators: Research strategies and clinical developments. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2014,</strong> <em>1841 </em>
                                    (5)
                                     , 745-758. <a href="https://doi.org/10.1016/j.bbalip.2013.11.001" title="DOI URL">https://doi.org/10.1016/j.bbalip.2013.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2013.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DSecond%252Bgeneration%252BS1P%252Bpathway%252Bmodulators%25253A%252BResearch%252Bstrategies%252Band%252Bclinical%252Bdevelopments%26aulast%3DBigaud%26aufirst%3DMarc%26date%3D2014%26volume%3D1841%26issue%3D5%26spage%3D745%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Hanson</span>, <span class="hlFld-ContribAuthor ">Robert  Peach</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Biology of the S1P1 Receptor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 23-53. <a href="https://doi.org/10.1007/978-3-319-05879-5_2" title="DOI URL">https://doi.org/10.1007/978-3-319-05879-5_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-05879-5_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-05879-5_2%26sid%3Dliteratum%253Aachs%26atitle%3DStructural%252BBiology%252Bof%252Bthe%252BS1P1%252BReceptor%26aulast%3DHanson%26aufirst%3DMichael%2BA.%26date%3D2014%26date%3D2014%26spage%3D23%26epage%3D53%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSphingosine-1-Phosphate%252BSignaling%252Bin%252BImmunology%252Band%252BInfectious%252BDiseases%26aulast%3DOldstone%26aufirst%3DMichael%2BB.%2BA.%26date%3D2014%26volume%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariangela  Urbano</span>, <span class="hlFld-ContribAuthor ">Miguel  Guerrero</span>, <span class="hlFld-ContribAuthor ">Hugh  Rosen</span>, <span class="hlFld-ContribAuthor ">Edward  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Modulators of the Sphingosine 1-phosphate receptor 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6377-6389. <a href="https://doi.org/10.1016/j.bmcl.2013.09.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DModulators%252Bof%252Bthe%252BSphingosine%252B1-phosphate%252Breceptor%252B1%26aulast%3DUrbano%26aufirst%3DMariangela%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6377%26epage%3D6389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and early data for racemic HTS hit compound <b>1</b> and optically pure analogues <b>2</b> and <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of treatment with compounds <b>12</b> and <b>15</b> on MDA-MB-231T tumor volume. Tumor weight is an average of 10 animals per group on day of the indicated treatment. Dosing period was days 14â28.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of treatment with compounds <b>37</b> and <b>38</b> on MDA-MB-231T tumor volume. Tumor weight is an average of 10 animals per group on day of the indicated treatment. Dosing was days 14â28.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacokinetic profile of <b>37</b> in monkey. Compound <b>37</b> dosed at 3 mpk in male cynomolgus monkeys. The iv and po formulation was 5% EtOH/45% PEG400/water.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, 4-phenoxyaniline; (b) HCl (4 N in dioxane); (c) RCOOH, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, R-NH<sub>2</sub>; (b) HCl (4 N in dioxane); (c), HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF, 2-(1<i>H</i>-imidazol-5-yl)acetic acid.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, 4-phenoxyaniline or 4-(4-chlorophenoxy)aniline; (b) HCl (4 N in dioxane); (c) HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF, 2-(1<i>H</i>-imidazol-5-yl)acetic acid.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (b) AcOH, 60 Â°C; (c) HCl (4 N in dioxane); (d) 4-imidazoleacetic acid hydrochloride, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) 4-(4-fluorophenoxy)aniline, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (b) HCl (4 N in dioxane); (c) 2-(1<i>H</i>-imidazol-5-yl)acetic acid hydrochloride, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (d) H<sub>2</sub>, Pd/C, MeOH; (e) benzaldehyde, MeOH, NaBH(OAc)<sub>3</sub>.</p></p></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) <i>t</i>-BuOAc, HClO<sub>4</sub>; (b) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>3</sub>CN; (c) LiHMDS, THF, R-Br, â78 Â°C; (d) LiBEt<sub>3</sub>H, THF, â78 Â°C; (e) Et<sub>3</sub>SiH, BF<sub>3</sub>.Et<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C; (g) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-diisopropylethylamine, dioxane, CH<sub>3</sub>CN; (h) 4-(4-fluorophenoxy)aniline or 4-phenoxyaniline, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (j) Râ²CH<sub>2</sub>COOH, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) HATU, DMF, <i>N</i>,<i>N</i>-diisopropylethylamine, 4-(4-fluorophenoxy)aniline; (b) HCl (4 N in dioxane); (c) 2-(1<i>H</i>-1,2,4-triazol-1-yl)acetic acid, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (d) DMSO, (COCl)<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, DCM, NEt<sub>3</sub>, â78 Â°C; (e) 4-fluorobenzyltriphenylphosphine chloride, DMSO, NaH, 70 Â°C; (f) Pd/C (10%), MeOH, H<sub>2</sub>.</p></p></figure><figure data-id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/medium/jm-2011-01533b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201533b/production/images/large/jm-2011-01533b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201533b&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) TsOH; (b) Boc<sub>2</sub>O, <i>N</i>,<i>N</i>-diisopropylethylamine, CH<sub>3</sub>CN; (c) LiHMDS, THF, 1-(bromomethyl)-4-fluorobenzene, â78 Â°C; (d) LiBEt<sub>3</sub>H, THF, â78 Â°C; (e) Et<sub>3</sub>SiH, BF<sub>3</sub>.Et<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, â78 Â°C; (f) KOH, MeOH; (g) 4-(4-fluorophenoxy)aniline, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF; (h) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (i) 2-(1<i>H</i>-1,2,3-triazol-1-yl)acetic acid, HATU, <i>N</i>,<i>N</i>-diisopropylethylamine, DMF.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">â</span> <span class="NLM_lpage">167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1991&pages=155-167&author=H.+Zhangauthor=N.+N.+Desaiauthor=A.+Oliveraauthor=T.+Sekiauthor=G.+Brookerauthor=S.+Spiegel&title=Sphingosine-1-phosphate%2C+a+novel+lipid%2C+involved+in+cellular+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDesai%26aufirst%3DN.%2BN.%26aulast%3DOlivera%26aufirst%3DA.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DBrooker%26aufirst%3DG.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%252C%2520a%2520novel%2520lipid%252C%2520involved%2520in%2520cellular%2520proliferation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1991%26volume%3D114%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cuvillier, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirianov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleuser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanek, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coso, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutkind, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">381</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">â</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1038%2F381800a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=8657285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=1996&pages=800-803&author=O.+Cuvillierauthor=G.+Pirianovauthor=B.+Kleuserauthor=P.+G.+Vanekauthor=O.+A.+Cosoauthor=J.+S.+Gutkindauthor=S.+Spiegel&title=Suppression+of+ceramide-mediated+programmed+cell+death+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate</span></div><div class="casAuthors">Cuvillier, Olivier; Pirianov, Grisha; Kleuser, Burkhard; Vanek, Philip G.; Coso, Omar A.; Gutkind, J. Silvio; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">6585</span>),
    <span class="NLM_cas:pages">800-803</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Ceramide is an important regulatory participant of programmed cell death (apoptosis) induced by tumor-necrosis factor (TMF)-Î± and Fas ligand, members of the TNF superfamily.  Conversely, sphingosine and sphingosine-1-phosphate, which are metabolites of ceramide, induce mitogenesis and have been implicated as second messengers in cellular proliferation induced by platelet-derived growth factor and serum.  Here we report that sphingosine-1-phosphate prevents the appearance of the key features of apoptosis, namely intranucleosomal DNA fragmentation and morphol. changes, which result from increased concns. of ceramide.  Furthermore, inhibition of ceramide-mediated apoptosis by activation of protein kinase C results from stimulation of sphingosine kinase and the concomitant increase in intracellular sphingosine-1-phosphate.  Finally sphingosine-1-phosphate not only stimulates the extracellular signal-regulated kinase (ERK) pathway, it counteracts the ceramide-induced activation of stress-activated protein kinase of ceramide and sphingosine-1-phosphate and their regulatory effects on different family members of mitogen-activated protein kinases dets. the fate of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3xEuzICMjarVg90H21EOLACvtfcHk0ljDHjE2yZIEAw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvVKnsro%253D&md5=50d91e59dc03600594fd0a236ecc2838</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F381800a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F381800a0%26sid%3Dliteratum%253Aachs%26aulast%3DCuvillier%26aufirst%3DO.%26aulast%3DPirianov%26aufirst%3DG.%26aulast%3DKleuser%26aufirst%3DB.%26aulast%3DVanek%26aufirst%3DP.%2BG.%26aulast%3DCoso%26aufirst%3DO.%2BA.%26aulast%3DGutkind%26aufirst%3DJ.%2BS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSuppression%2520of%2520ceramide-mediated%2520programmed%2520cell%2520death%2520by%2520sphingosine-1-phosphate%26jtitle%3DNature%26date%3D1996%26volume%3D381%26spage%3D800%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brocklyn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Movafagh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukowska-Grojec, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate stimulates cell migration through a G<sub>i</sub>-coupled cell surface receptor: potential involvement in angiogenesis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">35343</span><span class="NLM_x">â</span> <span class="NLM_lpage">35350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=35343-35350&author=F.+Wangauthor=J.+R.+Van+Brocklynauthor=J.+P.+Hobsonauthor=S.+Movafaghauthor=Z.+Zukowska-Grojecauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+1-phosphate+stimulates+cell+migration+through+a+Gi-coupled+cell+surface+receptor%3A+potential+involvement+in+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DHobson%26aufirst%3DJ.%2BP.%26aulast%3DMovafagh%26aufirst%3DS.%26aulast%3DZukowska-Grojec%26aufirst%3DZ.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520stimulates%2520cell%2520migration%2520through%2520a%2520Gi-coupled%2520cell%2520surface%2520receptor%253A%2520potential%2520involvement%2520in%2520angiogenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D35343%26epage%3D35350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lee, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claffey, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ancellin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaâafi, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">â</span> <span class="NLM_lpage">312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=301-312&author=M.-J.+Leeauthor=S.+Thangadaauthor=K.+P.+Claffeyauthor=N.+Ancellinauthor=C.+H.+Liuauthor=M.+Klukauthor=M.+Volpiauthor=R.+I.+Sha%E2%80%99afiauthor=T.+Hla&title=Vascular+endothelial+cell+adherens+junction+assembly+and+morphogenesis+induced+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-J.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DClaffey%26aufirst%3DK.%2BP.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DKluk%26aufirst%3DM.%26aulast%3DVolpi%26aufirst%3DM.%26aulast%3DSha%25E2%2580%2599afi%26aufirst%3DR.%2BI.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DVascular%2520endothelial%2520cell%2520adherens%2520junction%2520assembly%2520and%2520morphogenesis%2520induced%2520by%2520sphingosine-1-phosphate%26jtitle%3DCell%26date%3D1999%26volume%3D99%26spage%3D301%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Graeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">4084</span><span class="NLM_x">â</span> <span class="NLM_lpage">4087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=4084-4087&author=M.+Graelerauthor=G.+Shankarauthor=E.+J.+Goetzl&title=Cutting+edge%3A+suppression+of+T+cell+chemotaxis+by+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraeler%26aufirst%3DM.%26aulast%3DShankar%26aufirst%3DG.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DCutting%2520edge%253A%2520suppression%2520of%2520T%2520cell%2520chemotaxis%2520by%2520sphingosine%25201-phosphate%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D4084%26epage%3D4087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lee, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brocklyn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzeleev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">1552</span><span class="NLM_x">â</span> <span class="NLM_lpage">1555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1998&pages=1552-1555&author=M.-J.+Leeauthor=J.+R.+Van+Brocklynauthor=S.+Thangadaauthor=C.+H.+Liuauthor=A.+R.+Handauthor=R.+Menzeleevauthor=S.+Spiegelauthor=T.+Hla&title=Sphingosine-1-phosphate+as+a+ligand+for+the+G+protein-coupled+receptor+EDG-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-J.%26aulast%3DVan%2BBrocklyn%26aufirst%3DJ.%2BR.%26aulast%3DThangada%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DHand%26aufirst%3DA.%2BR.%26aulast%3DMenzeleev%26aufirst%3DR.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DSphingosine-1-phosphate%2520as%2520a%2520ligand%2520for%2520the%2520G%2520protein-coupled%2520receptor%2520EDG-1%26jtitle%3DScience%26date%3D1998%26volume%3D279%26spage%3D1552%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, T.</span><span> </span><span class="NLM_article-title">An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">â</span> <span class="NLM_lpage">9313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=9308-9313&author=T.+Hlaauthor=T.+Maciag&title=An+abundant+transcript+induced+in+differentiating+human+endothelial+cells+encodes+a+polypeptide+with+structural+similarities+to+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHla%26aufirst%3DT.%26aulast%3DMaciag%26aufirst%3DT.%26atitle%3DAn%2520abundant%2520transcript%2520induced%2520in%2520differentiating%2520human%2520endothelial%2520cells%2520encodes%2520a%2520polypeptide%2520with%2520structural%2520similarities%2520to%2520G-protein-coupled%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D9308%26epage%3D9313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeldt, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nava, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">â</span> <span class="NLM_lpage">961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=951-961&author=Y.+Liuauthor=R.+Wadaauthor=T.+Yamashitaauthor=Y.+Miauthor=C.+X.+Dengauthor=J.+P.+Hobsonauthor=H.+M.+Rosenfeldtauthor=V.+E.+Navaauthor=S.+S.+Chaeauthor=M.+J.+Leeauthor=C.+H.+Liuauthor=T.+Hlaauthor=S.+Spiegelauthor=R.+L.+Proia&title=Edg-1%2C+the+G+protein-coupled+receptor+for+sphingosine-1-phosphate%2C+is+essential+for+vascular+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWada%26aufirst%3DR.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DC.%2BX.%26aulast%3DHobson%26aufirst%3DJ.%2BP.%26aulast%3DRosenfeldt%26aufirst%3DH.%2BM.%26aulast%3DNava%26aufirst%3DV.%2BE.%26aulast%3DChae%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DC.%2BH.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DEdg-1%252C%2520the%2520G%2520protein-coupled%2520receptor%2520for%2520sphingosine-1-phosphate%252C%2520is%2520essential%2520for%2520vascular%2520maturation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26spage%3D951%26epage%3D961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">â</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lhShTkbu2NUrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+modulators+of+sphingosine-1-phosphate+receptors+as+barrier-oriented+therapeutic+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptors%2520as%2520barrier-oriented%2520therapeutic%2520molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">â</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+J.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+progress+in+the+development+of+selective+S1P1+receptor+agonists+for+the+treatment+of+inflammatory+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lhShTkbu2NUrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selective%2520S1P1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yonesu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span> </span><span class="NLM_article-title">A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1500</span><span class="NLM_x">â</span> <span class="NLM_lpage">1505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1248%2Fbpb.33.1500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=20823564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKlu7bO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=1500-1505&author=K.+Yonesuauthor=T.+Nakamuraauthor=Y.+Mizunoauthor=C.+Suzukiauthor=T.+Nagayamaauthor=S.+Satohauthor=F.+Nara&title=A+novel+sphingosine-1-phosphate+receptor+1+antagonist+prevents+the+proliferation+and+relaxation+of+vascular+endothelial+cells+by+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate</span></div><div class="casAuthors">Yonesu, Kiyoaki; Nakamura, Tsuyoshi; Mizuno, Yumiko; Suzuki, Chie; Nagayama, Takahiro; Satoh, Susumu; Nara, Futoshi</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1500-1505</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A sphingosine-1-phosphate receptor 1 (S1P1) antagonist is expected to be an anti-angiogenic compd.; however, there are few reports that demonstrated that a S1P1 inhibitor improved the disease state in an angiogenic animal model.  Since we detd. that a prototype S1P1 antagonist was an in vivo angiogenesis inhibitor, we developed the derivs. to acquire more effective compds.  In this report, we show the S1P1 antagonistic activity of some representatives, esp. compd. 5 {sodium 4-[(4-butoxyphenyl)thio]-2'-[{4-[(heptylthio)methyl]-2-hydroxyphenyl}(hydroxy)methyl]biphenyl-3-sulfonate}.  The IC50 values calcd. from an intracellular cAMP measurement assay and a [33P]sphingosine-1-phosphate (Sph-1-P)/S1P1 binding assay were 38 and 200 nM, resp.  A subtype specificity test for the other Sph-1-P receptors showed that compd. 5 was the S1P1-directional antagonist.  It also inhibited the proliferation, migration, and tube formation of human umbilical vein endothelial cells stimulated by Sph-1-P with the IC50 values of 18, 650, and 230 nM, resp.  A cytotoxicity assay concurrently performed with a tube formation assay supported the hypothesis that these biol. effects were not due to its cytotoxicity.  Furthermore, administration (10 mg/kg, i.v.) to anesthetized Sprague-Dawley rats inhibited Sph-1-P-induced hypotension by 100-90% for 30 min.  This is presumably through the inhibition of Sph-1-P-induced vasorelaxation, mainly by the blocking of S1P1 and/or S1P3.  Taken together, these results show that compd. 5 is an inhibitor of in vitro and in vivo Sph-1-P signaling, and that it will be useful to elucidate the in vivo effect of Sph-1-P on vascular endothelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5mMWxMxOoMLVg90H21EOLACvtfcHk0lhShTkbu2NUrw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKlu7bO&md5=64b11266689f0a99f1bbd2f498ab7e2c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1248%2Fbpb.33.1500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.33.1500%26sid%3Dliteratum%253Aachs%26aulast%3DYonesu%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DC.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DSatoh%26aufirst%3DS.%26aulast%3DNara%26aufirst%3DF.%26atitle%3DA%2520novel%2520sphingosine-1-phosphate%2520receptor%25201%2520antagonist%2520prevents%2520the%2520proliferation%2520and%2520relaxation%2520of%2520vascular%2520endothelial%2520cells%2520by%2520sphingosine-1-phosphate%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D33%26spage%3D1500%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonesu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, S.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of a novel class of S1P<sub>1</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3548</span><span class="NLM_x">â</span> <span class="NLM_lpage">3564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=3548-3564&author=T.+Nakamuraauthor=K.+Yonesuauthor=Y.+Mizunoauthor=C.+Suzukiauthor=Y.+Sakataauthor=Y.+Takuwaauthor=F.+Naraauthor=S.+Satoh&title=Synthesis+and+SAR+studies+of+a+novel+class+of+S1P1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DYonesu%26aufirst%3DK.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DC.%26aulast%3DSakata%26aufirst%3DY.%26aulast%3DTakuwa%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DSatoh%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520a%2520novel%2520class%2520of%2520S1P1%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D3548%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheu, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P<sub>1</sub> antagonist in vivo</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">â</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201533b&amp;key=10.1038%2Fnchembio804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm201533b&amp;key=16829954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFyqsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=434-441&author=M.+G.+Sannaauthor=S.+K.+Wangauthor=P.+J.+Gonzalez-Cabreraauthor=A.+Donauthor=D.+Marsolaisauthor=M.+P.+Matheuauthor=S.+H.+Weiauthor=I.+Parkerauthor=E.+Joauthor=W.+Chengauthor=M.+D.+Cahalanauthor=C.-H.+Wongauthor=H.+Rosen&title=Enhancement+of+capillary+leakage+and+restoration+of+lymphocyte+egress+by+a+chiral+S1P1+antagonist+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo</span></div><div class="casAuthors">Sanna, M. Germana; Wang, Sheng-Kai; Gonzalez-Cabrera, Pedro J.; Don, Anthony; Marsolais, David; Matheu, Melanie P.; Wei, Sindy H.; Parker, Ian; Jo, Euijung; Cheng, Wei-Chieh; Cahalan, Michael D.; Wong, Chi-Huey; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">434-441</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P, 1) regulates vascular barrier and lymphoid development, as well as lymphocyte egress from lymphoid organs, by activating high-affinity S1P1 receptors.  The authors used reversible chem. probes (i) to gain mechanistic insights into S1P systems organization not accessible through genetic manipulations and (ii) to investigate their potential for therapeutic modulation.  Vascular (but not airway) administration of the preferred R enantiomer of an in vivo-active chiral S1P11 receptor antagonist induced loss of capillary integrity in mouse skin and lung.  In contrast, the antagonist did not affect the no. of constitutive blood lymphocytes.  Instead, alteration of lymphocyte trafficking and phenotype required supraphysiol. elevation of S1P1 tone and was reversed by the antagonist.  In vivo two-photon imaging of lymph nodes confirmed requirements for obligate agonism, and the data were consistent with the presence of a stromal barrier mechanism for gating lymphocyte egress.  Thus, chem. modulation reveals differences in S1P-S1P1 'set points' among tissues and highlights both mechanistic advantages (lymphocyte sequestration) and risks (pulmonary edema) of therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3H_AoUm7AkrVg90H21EOLACvtfcHk0liDaHvficMX6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFyqsrw%253D&md5=c7cf6472393abe2d43851c5cd329e968</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnchembio804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio804%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DS.%2BK.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DDon%26aufirst%3DA.%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DMatheu%26aufirst%3DM.%2BP.%26aulast%3DWei%26aufirst%3DS.%2BH.%26aulast%3DParker%26aufirst%3DI.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DW.%26aulast%3DCahalan%26aufirst%3DM.%2BD.%26aulast%3DWong%26aufirst%3DC.-H.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DEnhancement%2520of%2520capillary%2520leakage%2520and%2520restoration%2520of%2520lymphocyte%2520egress%2520by%2520a%2520chiral%2520S1P1%2520antagonist%2520in%2520vivo%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D434%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Inoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span> </span><span class="NLM_article-title">Negative regulation of endothelial morphogenesis and angiogenesis by S1P<sub>2</sub> receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">â</span> <span class="NLM_lpage">300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2006&pages=293-300&author=I.+Inokiauthor=N.+Takuwaauthor=N.+Sugimotoauthor=K.+Yoshiokaauthor=S.+Takataauthor=S.+Kanekoauthor=Y.+Takuwa&title=Negative+regulation+of+endothelial+morphogenesis+and+angiogenesis+by+S1P2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoki%26aufirst%3DI.%26aulast%3DTakuwa%26aufirst%3DN.%26aulast%3DSugimoto%26aufirst%3DN.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DTakata%26aufirst%3DS.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DTakuwa%26aufirst%3DY.%26atitle%3DNegative%2520regulation%2520of%2520endothelial%2520morphogenesis%2520and%2520angiogenesis%2520by%2520S1P2%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D346%26spage%3D293%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Euijung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anh, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">â</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=J.+Euijungauthor=C.+Alfonsoauthor=M.-Y.+Anhauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DEuijung%26aufirst%3DJ.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAnh%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ryan, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span> </span><span class="NLM_article-title">ZD6474âa novel inhibitor of VEGFR and EGFR tyrosine kinase activity</span> <span class="citation_source-journal">Br. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">S6</span><span class="NLM_x">â</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=S6-S13&author=A.+J.+Ryanauthor=S.+R.+Wedge&title=ZD6474%E2%80%94a+novel+inhibitor+of+VEGFR+and+EGFR+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26atitle%3DZD6474%25E2%2580%2594a%2520novel%2520inhibitor%2520of%2520VEGFR%2520and%2520EGFR%2520tyrosine%2520kinase%2520activity%26jtitle%3DBr.%2520J.%2520Cancer.%26date%3D2005%26volume%3D92%26spage%3DS6%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">â</span> <span class="NLM_lpage">6665</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benzyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benzyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">â</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201533b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=Y.-H.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area â¤140 Ã2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljRNwW60QJ7Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DY.-H.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ibrahim, M. A.; Jeong, J. W.; Johnson, H. W. B.; Kearney, P.; Leahy, J. W.; Lewis, G. L.; Noguchi, R. T.; Nuss, J. M.</span><span> </span><span class="NLM_article-title">Sphingosine-1-Phosphate Receptor Antagonists</span>. PCT Int. Appl. WO201045580A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+A.+Ibrahim&author=J.+W.+Jeong&author=H.+W.+B.+Johnson&author=P.+Kearney&author=J.+W.+Leahy&author=G.+L.+Lewis&author=R.+T.+Noguchi&author=J.+M.+Nuss&title=Sphingosine-1-Phosphate+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIbrahim%26aufirst%3DM.%2BA.%26atitle%3DSphingosine-1-Phosphate%2520Receptor%2520Antagonists%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miranda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, M.</span><span> </span><span class="NLM_article-title">Amino acid synthesis using (<span class="smallcaps smallerCapital">l</span>)-pyroglutamic acid as a chiral starting material</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">7459</span><span class="NLM_x">â</span> <span class="NLM_lpage">7468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=7459-7468&author=J.+E.+Baldwinauthor=T.+Mirandaauthor=M.+Maloney&title=Amino+acid+synthesis+using+%28l%29-pyroglutamic+acid+as+a+chiral+starting+material"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DMiranda%26aufirst%3DT.%26aulast%3DMaloney%26aufirst%3DM.%26atitle%3DAmino%2520acid%2520synthesis%2520using%2520%2528l%2529-pyroglutamic%2520acid%2520as%2520a%2520chiral%2520starting%2520material%26jtitle%3DTetrahedron%26date%3D1989%26volume%3D45%26spage%3D7459%26epage%3D7468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambal, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A. N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.-C.</span><span> </span><span class="NLM_article-title">Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7333</span><span class="NLM_x">â</span> <span class="NLM_lpage">7342</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0500830" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7333-7342&author=C.+R.+Ganellinauthor=P.+B.+Bishopauthor=R.+B.+Bambalauthor=S.+M.+T.+Chanauthor=B.+Leblondauthor=A.+N.+J.+Mooreauthor=L.+Zhaoauthor=P.+Bourgeatauthor=C.+Roseauthor=F.+Vargasauthor=J.-C.+Schwartz&title=Inhibitors+of+tripeptidyl+peptidase+II.+3.+Derivation+of+butabindide+by+successive+structure+optimizations+leading+to+a+potential+general+approach+to+designing+exopeptidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0500830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0500830%26sid%3Dliteratum%253Aachs%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DBishop%26aufirst%3DP.%2BB.%26aulast%3DBambal%26aufirst%3DR.%2BB.%26aulast%3DChan%26aufirst%3DS.%2BM.%2BT.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DMoore%26aufirst%3DA.%2BN.%2BJ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DBourgeat%26aufirst%3DP.%26aulast%3DRose%26aufirst%3DC.%26aulast%3DVargas%26aufirst%3DF.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26atitle%3DInhibitors%2520of%2520tripeptidyl%2520peptidase%2520II.%25203.%2520Derivation%2520of%2520butabindide%2520by%2520successive%2520structure%2520optimizations%2520leading%2520to%2520a%2520potential%2520general%2520approach%2520to%2520designing%2520exopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7333%26epage%3D7342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a href="/doi/suppl/10.1021/jm201533b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82354"></div></div></div></div></div><hr /></hr><p class="last">Materials and methods used in determination of pharmacokinetic, efficacy, MLM oxidation, and CYP450 inhibition data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201533b/suppl_file/jm201533b_si_001.pdf">jm201533b_si_001.pdf (108.27 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201533b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-3%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm201533b%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201533b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b441d5b6ed197","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
